[S-1] Innventure, Inc. Files IPO Registration Statement
Innventure, Inc. filed a Form S-1 registering for resale up to 24,250,470 shares of common stock to be offered from time to time by selling stockholders. The registered shares comprise: up to 12,000,000 shares issuable upon conversion of Yorkville convertible debentures; up to 9,000,000 shares that may be issued and sold to Yorkville under the Standby Equity Purchase Agreement (SEPA); and 3,250,470 shares tied to October 3, 2025 Subscription Agreements, including 1,625,235 already issued and 1,625,235 issuable upon exercise of Series A Warrants.
The company will not receive proceeds from sales by the selling stockholders. It may receive up to the remaining approximately $67.0 million in aggregate gross proceeds from future SEPA sales, subject to conditions in the SEPA and related agreements, and de minimis proceeds if the Series A Warrants are exercised for cash. Conversions are subject to a 4.99% beneficial ownership cap and NASDAQ exchange caps. Innventure’s common stock trades on NASDAQ under “INV”; the last reported price was $3.00 per share on October 22, 2025.
Innventure, Inc. ha presentato un modulo S-1 per la registrazione per la vendita di fino a 24.250.470 azioni ordinarie da offrire periodicamente dagli azionisti venditori. Le azioni registrate comprendono: fino a 12.000.000 azioni emittibili mediante conversione di obbligazioni convertibili Yorkville; fino a 9.000.000 azioni che possono essere emesse e vendute a Yorkville ai sensi dell'Accordo di Acquisto Standby di Capitale (SEPA); e 3.250.470 azioni legate agli Accordi di Sottoscrizione del 3 ottobre 2025, tra cui 1.625.235 già emesse e 1.625.235 emittibili all'esercizio delle Warrants di Serie A.
L'azienda non riceverà proventi dalle vendite degli azionisti venditori. Potrà ricevere fino ai restanti circa 67,0 milioni di dollari in proventi lordi aggregati da future vendite SEPA, soggetti alle condizioni nel SEPA e negli accordi correlati, e proventi minimi se le Warrants di Serie A sono esercitate in contanti. Le conversioni sono soggette a una soglia di possesso beneficiario del 4,99% e ai limiti di scambio NASDAQ. Le azioni ordinarie Innventure sono negoziate sul NASDAQ con ticker “INV”; l'ultimo prezzo riportato era di 3,00 dollari per azione al 22 ottobre 2025.
Innventure, Inc. presentó un Formulario S-1 para registrar para la reventa hasta 24.250.470 acciones comunes que serán ofrecidas de vez en cuando por accionistas vendedores. Las acciones registradas comprenden: hasta 12.000.000 de acciones emitibles mediante conversión de obligaciones convertibles de Yorkville; hasta 9.000.000 de acciones que pueden emitirse y venderse a Yorkville en virtud del Standby Equity Purchase Agreement (SEPA); y 3.250.470 de acciones vinculadas a los Acuerdos de Suscripción del 3 de octubre de 2025, incluyendo 1.625.235 ya emitidas y 1.625.235 emitibles al ejercicio de las Warrants de Serie A.
La empresa no recibirá ingresos por las ventas de los accionistas vendedores. Podrá recibir hasta los restantes aproximadamente 67,0 millones de dólares en ingresos brutos agregados de futuras ventas SEPA, sujeto a las condiciones en el SEPA y acuerdos relacionados, y ingresos mínimos si las Warrants de Serie A se ejercen en efectivo. Las conversiones están sujetas a un límite de propiedad beneficiosa del 4,99% y a límites de intercambio NASDAQ. Las acciones comunes de Innventure cotizan en NASDAQ bajo “INV”; el último precio informado fue de 3,00 dólares por acción el 22 de octubre de 2025.
Innventure, Inc.은 매각 주주에 의해 필요 시 매매되도록 최대 24,250,470주를 등록하기 위한 Form S-1을 제출했습니다. 등록된 주식은 다음으로 구성됩니다: Yorkville의 전환 가능 채무증권으로 전환될 수 있는 최대 12,000,000주; Standby Equity Purchase Agreement(SEPA) 하에서 Yorkville에 발행 및 매도될 수 있는 최대 9,000,000주; 및 2025년 10월 3일 구독계약과 관련된 3,250,470주로, 그중 이미 발행된 1,625,235주와 행사 시 발행 가능한 1,625,235주를 포함합니다.
회사는 매각 주주들의 매각으로부터 수익을 받지 않습니다. SEPA 조건 및 관련 계약의 조건에 따라 향후 SEPA 매매에서 합산 총수익 약 6,700만 달러까지 수익을 받을 수 있으며, 시리즈 A 워런트가 현금으로 행사될 경우 최소한의 수익이 발생할 수 있습니다. 전환은 4.99%의 유익 소유 한도 및 NASDAQ 거래 한도의 적용을 받습니다. Innventure의 보통주는 NASDAQ에서 “INV”로 거래되며, 2025년 10월 22일 기준 종가가 주당 3.00달러였습니다.
Innventure, Inc. a déposé un formulaire S-1 visant la revente de jusqu'à 24 250 470 actions ordinaires à offrir de temps à autre par les actionnaires vendeurs. Les actions enregistrées se composent de : jusqu'à 12 000 000 d'actions susceptibles d'être émises par conversion d'obligations convertibles Yorkville; jusqu'à 9 000 000 d'actions qui peuvent être émises et vendues à Yorkville en vertu de l'Accord d'Achat d'Équité de Secours (SEPA); et 3 250 470 d'actions liées aux Accords de Souscription du 3 octobre 2025, incluant 1 625 235 déjà émis et 1 625 235 pouvant être émis lors de l'exercice des warrants de Série A.
L'entreprise ne percevra pas de produits provenant des ventes des actionnaires vendeurs. Elle pourrait percevoir jusqu'aux montants restants d'environ 67,0 millions de dollars de produits bruts globaux issus de futures ventes SEPA, sous réserve des conditions du SEPA et des accords connexes, et des produits minimaux si les warrants de Série A sont exercés en espèces. Les conversions sont soumises à une limite de détention bénéficiaire de 4,99% et à des limites NASDAQ. Les actions ordinaires d'Innventure sont cotées à la NASDAQ sous le symbole « INV » ; le dernier cours publié était de 3,00 dollars par action au 22 octobre 2025.
Innventure, Inc. hat ein Formular S-1 eingereicht, um bis zu 24.250.470 Inhaberaktien zum Wiederverkauf zu registrieren, die von verkaufenden Aktionären von Zeit zu Zeit angeboten werden sollen. Die registrierten Aktien umfassen: bis zu 12.000.000 Aktien, die durch Umwandlung von Yorkville wandelbaren Anleihen ausgegeben werden können; bis zu 9.000.000 Aktien, die Yorkville gemäß dem Standby-Einkaufsvertrag (SEPA) ausgegeben und verkauft werden können; und 3.250.470 Aktien im Zusammenhang mit den Subscription Agreements vom 3. Oktober 2025, einschließlich 1.625.235 bereits ausgegebener Aktien und 1.625.235 bei Ausübung der Serie-A-Warrants auszugeben.
Das Unternehmen wird aus Verkäufen der verkaufenden Aktionäre keine Erlöse erhalten. Es kann bis zu den verbleibenden ungefähr 67,0 Mio. USD Bruttoerlösen aus zukünftigen SEPA-Verkäufen erhalten, vorbehaltlich der Bedingungen im SEPA und den dazugehörigen Vereinbarungen, sowie geringe Erlöse, wenn die Serie-A-Warrants bar ausgeübt werden. Umwandlungen unterliegen einer Beneficial-Ownership-Grenze von 4,99% sowie NASDAQ-Handelsgrenzen. Innventure-Aktien werden an der NASDAQ unter dem Kürzel „INV“ gehandelt; der zuletzt berichtete Kurs betrug am 22. Oktober 2025 3,00 USD pro Aktie.
قدمت Innventure, Inc. نموذج S-1 للتسجيل لإعادة البيع حتى 24,250,470 سهماً عائداً من الأسهم العادية ليتم عرضها من حين لآخر من قبل المساهمين البائعين. الأسهم المسجلة تتألف من: حتى 12,000,000 سهماً يمكن إصدارها من خلال تحويل سندات قابلة للتحويل من Yorkville؛ حتى 9,000,000 سهماً قد تُصدر وتباع لـYorkville بموجب اتفاق شراء الأسهم الاحتياطي (SEPA)؛ و3,250,470 سهماً مرتبطة باتفاقات الاشتراك في 3 أكتوبر 2025، بما في ذلك 1,625,235 صادرة بالفعل و1,625,235 قابلة للإصدار عند ممارسة سندات Serie A warrants.
لن تتلقى الشركة عوائد من مبيعات المساهمين البائعين. قد تتلقى حتى ما تبقى من نحو 67.0 مليون دولار كإيرادات إجمالية إجمالية من مبيعات SEPA المستقبلية، رهناً بشروط SEPA والاتفاقات ذات الصلة، وإيرادات دنيا إذا تم ممارسة warrants Serie A نقداً. تقييد التحويلات بحد ملكية مستفيد 4.99% وبحدود تبادل NASDAQ. أسهم Innventure العادية مدرجة في NASDAQ تحت الرمز “INV”; آخر سعر مُبلغ عنه كان 3.00 دولارات للسهم في 22 أكتوبر 2025.
- None.
- None.
Innventure, Inc. ha presentato un modulo S-1 per la registrazione per la vendita di fino a 24.250.470 azioni ordinarie da offrire periodicamente dagli azionisti venditori. Le azioni registrate comprendono: fino a 12.000.000 azioni emittibili mediante conversione di obbligazioni convertibili Yorkville; fino a 9.000.000 azioni che possono essere emesse e vendute a Yorkville ai sensi dell'Accordo di Acquisto Standby di Capitale (SEPA); e 3.250.470 azioni legate agli Accordi di Sottoscrizione del 3 ottobre 2025, tra cui 1.625.235 già emesse e 1.625.235 emittibili all'esercizio delle Warrants di Serie A.
L'azienda non riceverà proventi dalle vendite degli azionisti venditori. Potrà ricevere fino ai restanti circa 67,0 milioni di dollari in proventi lordi aggregati da future vendite SEPA, soggetti alle condizioni nel SEPA e negli accordi correlati, e proventi minimi se le Warrants di Serie A sono esercitate in contanti. Le conversioni sono soggette a una soglia di possesso beneficiario del 4,99% e ai limiti di scambio NASDAQ. Le azioni ordinarie Innventure sono negoziate sul NASDAQ con ticker “INV”; l'ultimo prezzo riportato era di 3,00 dollari per azione al 22 ottobre 2025.
Innventure, Inc. presentó un Formulario S-1 para registrar para la reventa hasta 24.250.470 acciones comunes que serán ofrecidas de vez en cuando por accionistas vendedores. Las acciones registradas comprenden: hasta 12.000.000 de acciones emitibles mediante conversión de obligaciones convertibles de Yorkville; hasta 9.000.000 de acciones que pueden emitirse y venderse a Yorkville en virtud del Standby Equity Purchase Agreement (SEPA); y 3.250.470 de acciones vinculadas a los Acuerdos de Suscripción del 3 de octubre de 2025, incluyendo 1.625.235 ya emitidas y 1.625.235 emitibles al ejercicio de las Warrants de Serie A.
La empresa no recibirá ingresos por las ventas de los accionistas vendedores. Podrá recibir hasta los restantes aproximadamente 67,0 millones de dólares en ingresos brutos agregados de futuras ventas SEPA, sujeto a las condiciones en el SEPA y acuerdos relacionados, y ingresos mínimos si las Warrants de Serie A se ejercen en efectivo. Las conversiones están sujetas a un límite de propiedad beneficiosa del 4,99% y a límites de intercambio NASDAQ. Las acciones comunes de Innventure cotizan en NASDAQ bajo “INV”; el último precio informado fue de 3,00 dólares por acción el 22 de octubre de 2025.
Innventure, Inc.은 매각 주주에 의해 필요 시 매매되도록 최대 24,250,470주를 등록하기 위한 Form S-1을 제출했습니다. 등록된 주식은 다음으로 구성됩니다: Yorkville의 전환 가능 채무증권으로 전환될 수 있는 최대 12,000,000주; Standby Equity Purchase Agreement(SEPA) 하에서 Yorkville에 발행 및 매도될 수 있는 최대 9,000,000주; 및 2025년 10월 3일 구독계약과 관련된 3,250,470주로, 그중 이미 발행된 1,625,235주와 행사 시 발행 가능한 1,625,235주를 포함합니다.
회사는 매각 주주들의 매각으로부터 수익을 받지 않습니다. SEPA 조건 및 관련 계약의 조건에 따라 향후 SEPA 매매에서 합산 총수익 약 6,700만 달러까지 수익을 받을 수 있으며, 시리즈 A 워런트가 현금으로 행사될 경우 최소한의 수익이 발생할 수 있습니다. 전환은 4.99%의 유익 소유 한도 및 NASDAQ 거래 한도의 적용을 받습니다. Innventure의 보통주는 NASDAQ에서 “INV”로 거래되며, 2025년 10월 22일 기준 종가가 주당 3.00달러였습니다.
Innventure, Inc. a déposé un formulaire S-1 visant la revente de jusqu'à 24 250 470 actions ordinaires à offrir de temps à autre par les actionnaires vendeurs. Les actions enregistrées se composent de : jusqu'à 12 000 000 d'actions susceptibles d'être émises par conversion d'obligations convertibles Yorkville; jusqu'à 9 000 000 d'actions qui peuvent être émises et vendues à Yorkville en vertu de l'Accord d'Achat d'Équité de Secours (SEPA); et 3 250 470 d'actions liées aux Accords de Souscription du 3 octobre 2025, incluant 1 625 235 déjà émis et 1 625 235 pouvant être émis lors de l'exercice des warrants de Série A.
L'entreprise ne percevra pas de produits provenant des ventes des actionnaires vendeurs. Elle pourrait percevoir jusqu'aux montants restants d'environ 67,0 millions de dollars de produits bruts globaux issus de futures ventes SEPA, sous réserve des conditions du SEPA et des accords connexes, et des produits minimaux si les warrants de Série A sont exercés en espèces. Les conversions sont soumises à une limite de détention bénéficiaire de 4,99% et à des limites NASDAQ. Les actions ordinaires d'Innventure sont cotées à la NASDAQ sous le symbole « INV » ; le dernier cours publié était de 3,00 dollars par action au 22 octobre 2025.
Innventure, Inc. hat ein Formular S-1 eingereicht, um bis zu 24.250.470 Inhaberaktien zum Wiederverkauf zu registrieren, die von verkaufenden Aktionären von Zeit zu Zeit angeboten werden sollen. Die registrierten Aktien umfassen: bis zu 12.000.000 Aktien, die durch Umwandlung von Yorkville wandelbaren Anleihen ausgegeben werden können; bis zu 9.000.000 Aktien, die Yorkville gemäß dem Standby-Einkaufsvertrag (SEPA) ausgegeben und verkauft werden können; und 3.250.470 Aktien im Zusammenhang mit den Subscription Agreements vom 3. Oktober 2025, einschließlich 1.625.235 bereits ausgegebener Aktien und 1.625.235 bei Ausübung der Serie-A-Warrants auszugeben.
Das Unternehmen wird aus Verkäufen der verkaufenden Aktionäre keine Erlöse erhalten. Es kann bis zu den verbleibenden ungefähr 67,0 Mio. USD Bruttoerlösen aus zukünftigen SEPA-Verkäufen erhalten, vorbehaltlich der Bedingungen im SEPA und den dazugehörigen Vereinbarungen, sowie geringe Erlöse, wenn die Serie-A-Warrants bar ausgeübt werden. Umwandlungen unterliegen einer Beneficial-Ownership-Grenze von 4,99% sowie NASDAQ-Handelsgrenzen. Innventure-Aktien werden an der NASDAQ unter dem Kürzel „INV“ gehandelt; der zuletzt berichtete Kurs betrug am 22. Oktober 2025 3,00 USD pro Aktie.
قدمت Innventure, Inc. نموذج S-1 للتسجيل لإعادة البيع حتى 24,250,470 سهماً عائداً من الأسهم العادية ليتم عرضها من حين لآخر من قبل المساهمين البائعين. الأسهم المسجلة تتألف من: حتى 12,000,000 سهماً يمكن إصدارها من خلال تحويل سندات قابلة للتحويل من Yorkville؛ حتى 9,000,000 سهماً قد تُصدر وتباع لـYorkville بموجب اتفاق شراء الأسهم الاحتياطي (SEPA)؛ و3,250,470 سهماً مرتبطة باتفاقات الاشتراك في 3 أكتوبر 2025، بما في ذلك 1,625,235 صادرة بالفعل و1,625,235 قابلة للإصدار عند ممارسة سندات Serie A warrants.
لن تتلقى الشركة عوائد من مبيعات المساهمين البائعين. قد تتلقى حتى ما تبقى من نحو 67.0 مليون دولار كإيرادات إجمالية إجمالية من مبيعات SEPA المستقبلية، رهناً بشروط SEPA والاتفاقات ذات الصلة، وإيرادات دنيا إذا تم ممارسة warrants Serie A نقداً. تقييد التحويلات بحد ملكية مستفيد 4.99% وبحدود تبادل NASDAQ. أسهم Innventure العادية مدرجة في NASDAQ تحت الرمز “INV”; آخر سعر مُبلغ عنه كان 3.00 دولارات للسهم في 22 أكتوبر 2025.
Innventure, Inc. 已提交 Form S-1,注册以便经由出售股东不时再售高达 24,250,470 股普通股。注册股包括:最多 12,000,000 股可通过 Yorkville 可转债转换而发行的股票;最多 9,000,000 股可根据 Standby Equity Purchase Agreement(SEPA)发行并向 Yorkville 出售的股票;以及 3,250,470 股与 2025 年 10 月 3 日认购协议相关的股份,其中包括已经发行的 1,625,235 股和在行使 Serie A Warrant 时可发行的 1,625,235 股。
本公司不会从出售股东的出售中获得收益。它可从未来 SEPA 销售中获得最多约 6,700 万美元的总毛收入,须受 SEPA 及相关协议的条件约束;如果 Serie A Warrant 以现金方式行使,可能获得最低额的收入。转换受 4.99% 的受益所有权上限和 NASDAQ 交易上限约束。Innventure 的普通股在 NASDAQ 交易,代码为“INV”;截至 2025 年 10 月 22 日,最新成交价为每股 3.00 美元。
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
Delaware
|
|
|
6770
|
|
|
93-4440048
|
|
(State or other jurisdiction of incorporation or organization)
|
|
|
(Primary Standard Industrial Classification Code Number)
|
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Large accelerated filer
|
|
|
☐
|
|
|
Accelerated filer
|
|
|
☐
|
|
|
|
|
☒
|
|
|
Smaller reporting company
|
|
|
|
|
|
|
|
|
|
|
Emerging growth company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
PRELIMINARY PROSPECTUS
|
|
|
SUBJECT TO COMPLETION
|
|
|
DATED OCTOBER 23, 2025
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
Page
|
|
ABOUT THIS PROSPECTUS
|
|
|
ii
|
|
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
|
|
|
iv
|
|
PROSPECTUS SUMMARY
|
|
|
1
|
|
RISK FACTORS
|
|
|
12
|
|
USE OF PROCEEDS
|
|
|
31
|
|
MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
|
32
|
|
BUSINESS
|
|
|
49
|
|
MANAGEMENT
|
|
|
64
|
|
EXECUTIVE AND DIRECTOR COMPENSATION OF INNVENTURE
|
|
|
70
|
|
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
|
|
|
78
|
|
DESCRIPTION OF SECURITIES
|
|
|
87
|
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT
|
|
|
92
|
|
SELLING STOCKHOLDERS
|
|
|
95
|
|
SHARES ELIGIBLE FOR FUTURE SALE
|
|
|
98
|
|
PLAN OF DISTRIBUTION
|
|
|
100
|
|
EXPERTS
|
|
|
101
|
|
LEGAL MATTERS
|
|
|
102
|
|
WHERE YOU CAN FIND MORE INFORMATION
|
|
|
102
|
|
INDEX TO FINANCIAL STATEMENTS
|
|
|
F-1
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
expectations regarding Innventure’s and the Innventure Companies’ (as defined below) ability to execute on strategies and
achieve future financial performance, including their respective future business plans, expansion and acquisition plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing,
operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and Innventure’s ability to invest in growth initiatives;
|
|
•
|
the implementation, market acceptance and success of Innventure’s and the Innventure Companies’ business models and growth
strategies;
|
|
•
|
Innventure’s and the Innventure Companies’ future capital requirements and sources and uses of cash;
|
|
•
|
sustained unfavorable economic or other conditions which could cause the need for Innventure to evaluate and potentially record
additional impairment charges for all, or a portion of, its goodwill and other intangible assets;
|
|
•
|
Innventure’s future capital requirements and sources and uses of cash, including: (i) Innventure’s ability to obtain funding for
its operations and future growth; and (ii) Innventure’s ability to continue as a going concern;
|
|
•
|
Innventure’s ability to maintain control over the Innventure Companies;
|
|
•
|
Innventure’s ability to meet the various conditions imposed by, and to satisfy its obligations to, the WTI Lenders (as defined
below), under the WTI Facility (as defined below);
|
|
•
|
Innventure’s access to funds under the SEPA (as defined herein) with Yorkville, including ownership limitations, issuances and
subscriptions based on trading volumes, and Innventure’s ability to continue to access the funds available under the SEPA or the Securities Purchase Agreement and related, unissued New Convertible Debentures due to certain conditions,
restrictions and limitations set forth therein;
|
|
•
|
certain restrictions and limitations set forth in Innventure’s debt instruments, which may impair Innventure’s financial and
operating flexibility;
|
|
•
|
Innventure’s and the Innventure Companies’ ability to generate liquidity and maintain sufficient capital to operate as
anticipated;
|
TABLE OF CONTENTS
|
•
|
Innventure’s and the Innventure Companies’ ability to obtain funding for their operations, future growth and to continue as
going concerns;
|
|
•
|
the risk that the technology solutions that Innventure and the Innventure Companies license or acquire from third parties or
develop internally may not function as anticipated or provide the benefits anticipated;
|
|
•
|
developments and projections relating to Innventure’s and the Innventure Companies’ competitors and industry;
|
|
•
|
the ability of Innventure and the Innventure Companies to scale the operations of their respective businesses;
|
|
•
|
the ability of Innventure and the Innventure Companies to establish substantial commercial sales of their products;
|
|
•
|
the ability of Innventure and the Innventure Companies to compete against companies with greater capital and other resources or
superior technology or products;
|
|
•
|
Innventure and the Innventure Companies’ ability to meet, and to continue to meet, applicable regulatory requirements for the
use of their respective products and the numerous regulatory requirements generally applicable to their businesses;
|
|
•
|
the outcome of any legal proceedings against Innventure or the Innventure Companies;
|
|
•
|
Innventure’s ability to find future opportunities to license or acquire breakthrough technology solutions from MNCs (as defined
below) or other third parties (collectively, “Technology Solutions Providers”) and to satisfy the requirements imposed by or to avoid disagreements with its current and future Technology Solutions Providers;
|
|
•
|
the risk that the launch of new companies distracts Innventure’s management from its subsidiaries and their respective
operations;
|
|
•
|
the risk that Innventure may be deemed an investment company under the Investment Company Act of 1940 (the “Investment Company
Act”), which would impose burdensome compliance requirements and restrictions on its activities;
|
|
•
|
Innventure’s ability to sufficiently protect the intellectual property (“IP”) rights of itself and its Operating Companies, and
to avoid or resolve in a timely and cost-effective manner any disputes that may arise relating to its use of the IP of third parties;
|
|
•
|
the risk of a cyber-attack or a failure of Innventure’s information technology and data security infrastructure;
|
|
•
|
geopolitical risk and changes in applicable laws or regulations, including with respect to foreign trade policy and tariffs;
|
|
•
|
potential adverse effects of other economic, business, and/or competitive factors;
|
|
•
|
operational risks related to Innventure and the Innventure Companies, which have limited or no operating history; and
|
|
•
|
the limited liquidity and trading of Innventure’s securities.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
Ownership Limitation: Yorkville shall not purchase or acquire any shares of Common
Stock pursuant to the SEPA that would result in it and its affiliates (on an aggregated basis) beneficially owning more than 9.99% of the then outstanding voting power or number of shares of Common Stock;
|
|
•
|
Registration Limitation: In no event shall an Advance exceed the amount of shares of
Common Stock registered under an effective registration statement that provides for the resale from time to time of the shares of Common Stock sold pursuant the SEPA;
|
|
•
|
Volume Limitation: In certain instances, if the total number of Common Stock traded
on NASDAQ during the applicable period is less than a specified threshold, then the number of shares issued and sold by the Company under the Advance will be limited to the greater of (a) 35% of the trading volume during the
applicable period or (b) the number of shares of Common Stock sold by Yorkville during the applicable period (in each case not to exceed the amount specified in the Advance and the other limitations under the SEPA); and
|
|
•
|
Minimum Acceptable Price: If the Company notifies Yorkville of a minimum acceptable
price (“MAP” as defined in the SEPA), then, if during the applicable period the VWAP of the Common Stock is below the specified MAP or there is no VWAP, the amount of Common Stock set forth in the Advance will be reduced by one third
(1/3rd); provided, however, that this lower amount may be increased if certain conditions are met.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
Innventure may not be able to obtain additional financing to fund the operations and growth of the business.
|
|
•
|
There is uncertainty regarding Innventure’s ability to maintain liquidity sufficient to operate its business effectively,
which raises substantial doubt about its ability to continue as a going concern.
|
|
•
|
Innventure’s principal revenues are expected to be earned in the future through its Operating Companies, including through
AeroFlexx, Accelsius and Refinity, and Innventure depends on its Operating Companies for cash.
|
|
•
|
Innventure may not be successful in finding future opportunities to license or acquire breakthrough technology solutions from
Technology Solutions Providers.
|
|
•
|
The Innventure Companies are currently early commercial stage companies that may never achieve or sustain profitability.
|
|
•
|
If Innventure or the Innventure Companies are not able to satisfy the requirements imposed by technology providers or have
disagreements with those technology providers, their relationships with these partners could deteriorate, which could have a material adverse effect on the business of Innventure and the Innventure Companies.
|
|
•
|
The WTI Facility may impair Innventure LLC’s, Innventure’s and the Operating Companies’ financial and operating flexibility.
|
|
•
|
It is not possible to predict the extent to which Innventure will, intends to, or may rely on Yorkville and the SEPA as a
source of funding.
|
|
•
|
It is not possible to predict the actual number of shares Innventure will sell under the SEPA or issue under the Convertible
Debentures to Yorkville, or the actual gross proceeds resulting from those sales, if applicable.
|
|
•
|
Innventure’s pursuit of new business strategies and acquisitions could disrupt its ongoing business, present risks not
originally contemplated and materially adversely affect its business, reputation, results of operations and financial condition.
|
|
•
|
The market price of our Common Stock is likely to be highly volatile, and you may lose some or all of your investment.
|
|
•
|
Volatility in Innventure’s share price could subject Innventure to securities class action litigation.
|
|
•
|
Future sales of shares of our Common Stock or other equity may depress its stock price.
|
|
•
|
Provisions in our Amended and Restated Certificate of Incorporation (the “A&R Certificate of Incorporation”) and under
Delaware law could discourage a takeover that stockholders may consider favorable and may lead to entrenchment of management.
|
|
•
|
Innventure is an emerging growth company and smaller reporting company, and Innventure cannot be certain if the reduced
reporting requirements applicable to emerging growth companies and smaller reporting companies will make its shares less attractive to investors.
|
|
•
|
Future offerings of debt or offerings or issuances of equity securities by the Innventure may adversely affect the market
price of the Common Stock or otherwise dilute all other stockholders.
|
|
•
|
If Innventure’s estimates or judgments relating to its critical accounting estimates prove to be incorrect or financial
reporting standards or interpretations change, Innventure’s results of operations could be adversely affected.
|
TABLE OF CONTENTS
|
•
|
The Company has identified material weaknesses in its internal controls over financial reporting that could, if not
remediated, result in material misstatements in its financial statements and which may have an impact on Innventure’s ability to timely or accurately report its financial condition or results of operations following the consummation
of the Business Combination.
|
|
•
|
If Innventure is deemed to be an investment company under the Investment Company Act, it may be required to institute
burdensome compliance requirements and its activities may be restricted, which may make it difficult to operate or to execute its growth plans.
|
|
•
|
AFX, Accelsius and Refinity are early-stage companies, and their limited operating histories makes it difficult to evaluate
their future prospects and the risks and challenges they may encounter.
|
|
•
|
Accelsius’ cooling products may be subject to increased regulatory scrutiny due to their use of working fluid refrigerants
that contain fluorine.
|
|
•
|
The market, including customers and potential investors, may be skeptical of the viability and benefits of Accelsius’ cooling
products and Refinity’s plastic waste recycling process because they are based on relatively novel and complex technology.
|
|
•
|
The failure of AFX’s suppliers to continue to deliver necessary raw materials or other components of its products in a timely
manner and to specification could prevent it from delivering products within required time frames and could cause production delays, cancellations, penalty payments and damage to its brand and reputation.
|
|
•
|
AFX may not be able to meet applicable regulatory requirements for the use of AFX’s products in food grade applications, and,
even if the requirements are met, complying on an ongoing basis with the numerous regulatory requirements applicable to AFX’s products and AFX’s facilities will be time-consuming and costly.
|
|
•
|
Innventure may be unable to sufficiently protect the IP rights of itself and the Innventure Companies and may encounter
disputes from time to time relating to its use of the IP of third parties.
|
|
•
|
Innventure, the Innventure Companies, and Innventure’s MNC partners may be negatively impacted by volatility in the political
and economic environment, such geopolitical unrest, economic downturns and increases in interest rates, and a period of sustained inflation, which could have an adverse impact on Innventure’s and the Innventure Companies’ business,
financial condition, results of operations and prospects.
|
|
•
|
Changes in U.S. or foreign trade policies, including additional tariffs or global trade conflicts, may adversely impact our
business and operating results.
|
|
•
|
Cyber-attacks or a failure in Innventure’s information technology and data security infrastructure could adversely affect
Innventure’s business and operations.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
develop and commercialize their products and processes;
|
|
•
|
design and deliver products and processes of acceptable performance that function as anticipated;
|
|
•
|
increase sales revenue;
|
|
•
|
forecast their revenue and budget for and manage their expenses;
|
|
•
|
attract new customers and commercial relationships;
|
|
•
|
compete successfully in the industry in which they operate;
|
|
•
|
plan for and manage capital expenditures for their current and future products and manage their supply chain and supplier
relationships related to their current and future products;
|
|
•
|
scale quickly enough due to capital and other resource constraints;
|
|
•
|
find, contract with, and retain reliable and commercially reasonable materials, components, manufacturers and inventory vendors;
|
|
•
|
comply with existing and new or modified laws and regulations applicable to their business in and outside the United States,
including compliance requirements of U.S. customs and export regulations;
|
TABLE OF CONTENTS
|
•
|
anticipate and respond to macroeconomic changes and changes in the markets in which they operate;
|
|
•
|
anticipate and respond to regulatory and/or environmental policies that impact the Innventure Companies’ plant operations;
|
|
•
|
maintain and enhance the value of their reputation and brand;
|
|
•
|
develop and protect IP;
|
|
•
|
hire, integrate and retain talented people at all levels of their organizations;
|
|
•
|
successfully defend themselves in any legal proceeding that may arise and enforce their rights in any legal proceedings they may
initiate; and
|
|
•
|
manage and mitigate the adverse effects on their business of any public health emergencies, natural disasters, widespread travel
disruptions, security risks including IT security, data privacy, cyber risks, international conflicts, geopolitical tension and other events beyond their control.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
actual or anticipated fluctuations in Innventure’s financial condition and operating results, including fluctuations in its
quarterly and annual results;
|
|
•
|
developments involving Innventure’s competitors;
|
|
•
|
changes in laws and regulations affecting Innventure’s business;
|
|
•
|
variations in Innventure’s operating performance and the performance of its competitors in general;
|
|
•
|
the public’s reaction to Innventure’s press releases, its other public announcements and its filings with the SEC;
|
|
•
|
additions and departures of key personnel;
|
|
•
|
announcements of significant acquisitions, strategic partnerships, joint ventures or capital commitments by Innventure or its
competitors;
|
|
•
|
Innventure’s failure to meet the estimates and projections of the investment community or that it may otherwise provide to the
public;
|
|
•
|
publication of research reports about Innventure’s industry, or positive or negative recommendations or withdrawal of research
coverage by securities analysts;
|
|
•
|
changes in the market valuations of similar companies;
|
|
•
|
overall performance of the equity markets;
|
|
•
|
sales of the Common Stock or preferred stock by Innventure or its stockholders in the future;
|
|
•
|
trading volume of the Common Stock;
|
|
•
|
significant lawsuits, including shareholder litigation;
|
|
•
|
failure to comply with the requirements of NASDAQ;
|
|
•
|
general economic, industry and market conditions other events or factors, many of which are beyond Innventure’s control; and
|
|
•
|
changes in accounting standards, policies, guidelines, interpretations or principles.
|
TABLE OF CONTENTS
|
•
|
a classified board of directors with three-year staggered terms, which may delay the ability of stockholders to change the
membership of a majority of the Board;
|
|
•
|
no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director
candidates;
|
|
•
|
the exclusive right of the Board, unless the Board grants such a right to the holders of any series of preferred stock, to elect
a director to fill a vacancy created by the expansion of the Board or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our Board;
|
|
•
|
the prohibition on removal of directors without cause;
|
|
•
|
the ability of the Board to authorize the issuance of shares of preferred stock and to determine the price and other terms of
those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;
|
TABLE OF CONTENTS
|
•
|
the ability of the Board to alter the Bylaws without obtaining stockholder approval;
|
|
•
|
the required approval of at least 2/3 of the shares entitled to vote to amend or repeal the Bylaws or amend, alter or repeal
certain provisions of the A&R Certificate of Incorporation;
|
|
•
|
a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special
meeting of Innventure’s stockholders;
|
|
•
|
an exclusive forum provision providing that the Court of Chancery of the State of Delaware (the “Delaware Court”) will be the
exclusive forum for certain actions and proceedings;
|
|
•
|
the requirement that a special meeting of stockholders may be called only by the Board, Innventure’s chief executive officer, or
the chairman of the Board, which may delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors;
|
|
•
|
advance notice procedures that stockholders must comply with in order to nominate candidates to the Board or to propose matters
to be acted upon at a stockholders’ meeting, which may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of
Innventure; and
|
|
•
|
Innventure is subject to the anti-takeover provisions contained in Section 203 of the Delaware General Corporation Law, which
will prevent Innventure from engaging in a business combination with any holder of 15% or more of its capital stock unless the holder has held the stock for three years or, among other exceptions, the Board has approved the transaction.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
restrictions on the nature of its investments;
|
|
•
|
limitations on its ability to borrow;
|
|
•
|
prohibitions on transactions with affiliates; and
|
|
•
|
restrictions on the issuance of securities.
|
|
•
|
registration as an investment company and subsequent regulation as an investment company;
|
|
•
|
adoption of a specific form of corporate structure; and
|
|
•
|
reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
|
|
|
|
|
|
|
Six months ended
June 30, 2025
|
|
|
Six months ended
June 30, 2024
|
|
|
Change
|
|||
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
Revenue
|
|
|
$700
|
|
|
$447
|
|
|
$253
|
|
|
56.6%
|
|
Operating Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of Sales
|
|
|
3,045
|
|
|
––
|
|
|
3,045
|
|
|
nm*
|
|
General and administrative
|
|
|
38,245
|
|
|
16,283
|
|
|
21,962
|
|
|
134.9%
|
|
Sales and marketing
|
|
|
4,304
|
|
|
2,549
|
|
|
1,755
|
|
|
68.9%
|
|
Research and development
|
|
|
12,321
|
|
|
3,433
|
|
|
8,888
|
|
|
258.9%
|
|
Goodwill impairment
|
|
|
346,557
|
|
|
––
|
|
|
346,557
|
|
|
nm*
|
|
Total Operating Expenses
|
|
|
404,472
|
|
|
22,265
|
|
|
382,207
|
|
|
1,716.6%
|
|
Loss from Operations
|
|
|
(403,772)
|
|
|
(21,818)
|
|
|
(381,954)
|
|
|
1,750.6%
|
|
Non-operating (Expense) and Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
(4,185)
|
|
|
(448)
|
|
|
(3,737)
|
|
|
834.2%
|
|
Net gain (loss) on investments
|
|
|
––
|
|
|
4,399
|
|
|
(4,399)
|
|
|
(100.0)%
|
|
Net gain (loss) on investments – due to related
parties
|
|
|
––
|
|
|
(160)
|
|
|
160
|
|
|
(100.0)%
|
|
Change in fair value of financial liabilities
|
|
|
23,605
|
|
|
(478)
|
|
|
24,083
|
|
|
(5,038.3)%
|
|
Equity method investment (loss) income
|
|
|
(8,680)
|
|
|
784
|
|
|
(9,464)
|
|
|
(1,207.1)%
|
|
Realized gain on conversion of available for sale
investment
|
|
|
1,507
|
|
|
––
|
|
|
1,507
|
|
|
nm*
|
|
Loss on extinguishment of related party debt
|
|
|
(3,538)
|
|
|
––
|
|
|
(3,538)
|
|
|
nm*
|
|
Loss on extinguishment of debt
|
|
|
(3,462)
|
|
|
––
|
|
|
(3,462)
|
|
|
nm*
|
|
Loss on conversion of promissory notes
|
|
|
––
|
|
|
(1,119)
|
|
|
1,119
|
|
|
(100.0)%
|
|
Miscellaneous other expense
|
|
|
(43)
|
|
|
––
|
|
|
(43)
|
|
|
nm*
|
|
Total Non-operating (Expense) Income
|
|
|
5,204
|
|
|
2,978
|
|
|
2,226
|
|
|
74.7%
|
|
Income tax benefit
|
|
|
(3,619)
|
|
|
––
|
|
|
(3,619)
|
|
|
nm*
|
|
Net Loss
|
|
|
(394,949)
|
|
|
(18,840)
|
|
|
(376,109)
|
|
|
1,996.3%
|
|
Less: net loss attributable to Non-redeemable
non-controlling interest
|
|
|
(167,725)
|
|
|
(6,333)
|
|
|
(161,392)
|
|
|
2,548.4%
|
|
Net Loss Attributable to
Innventure, Inc. Stockholders / Innventure LLC Unitholders
|
|
|
(227,224)
|
|
|
(12,507)
|
|
|
(214,717)
|
|
|
1,716.8%
|
|
Other comprehensive income, net of taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain (loss) on available for sale debt
securities – related party
|
|
|
(691)
|
|
|
––
|
|
|
(691)
|
|
|
nm*
|
|
Reclassification of realized gain on conversion of
available for sale investments
|
|
|
(1,507)
|
|
|
––
|
|
|
(1,507)
|
|
|
nm*
|
|
Total other comprehensive income, net of taxes
|
|
|
(2,198)
|
|
|
—
|
|
|
(2,198)
|
|
|
nm*
|
|
Total comprehensive loss, net of taxes
|
|
|
(397,147)
|
|
|
(18,840)
|
|
|
(378,307)
|
|
|
2,008.0%
|
|
Less: comprehensive loss attributable to
Non-redeemable non-controlling interest
|
|
|
(167,725)
|
|
|
(6,333)
|
|
|
(161,392)
|
|
|
2,548.4%
|
|
Net Comprehensive Loss
Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders
|
|
|
$(229,422)
|
|
|
$(12,507)
|
|
|
$(216,915)
|
|
|
1,734.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
not meaningful
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||||||
|
|
|
|
Three months ended
|
|
|
Six months ended
|
||||||
|
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
Net loss
|
|
|
$(141,275)
|
|
|
$(11,314)
|
|
|
$(394,949)
|
|
|
$(18,840)
|
|
Interest expense, net(1)
|
|
|
2,647
|
|
|
43
|
|
|
4,185
|
|
|
448
|
|
Depreciation and amortization expense
|
|
|
5,634
|
|
|
64
|
|
|
11,182
|
|
|
69
|
|
Income tax benefit
|
|
|
(2,220)
|
|
|
—
|
|
|
(3,619)
|
|
|
—
|
|
EBITDA
|
|
|
(135,214)
|
|
|
(11,207)
|
|
|
(383,201)
|
|
|
(18,323)
|
|
Transaction and other related costs(2)
|
|
|
—
|
|
|
2,769
|
|
|
—
|
|
|
6,041
|
|
Change in fair value of financial liabilities(3)
|
|
|
(7,176)
|
|
|
—
|
|
|
(23,605)
|
|
|
478
|
|
Stock-based compensation(4)
|
|
|
9,406
|
|
|
293
|
|
|
15,247
|
|
|
689
|
|
Goodwill impairment(5)
|
|
|
113,344
|
|
|
—
|
|
|
346,557
|
|
|
—
|
|
Loss on extinguishment of debt(6)
|
|
|
3,462
|
|
|
—
|
|
|
3,462
|
|
|
—
|
|
Loss on extinguishment of related party debt(7)
|
|
|
—
|
|
|
—
|
|
|
3,538
|
|
|
—
|
|
Loss on conversion of promissory notes
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,119
|
|
Adjusted EBITDA
|
|
|
$(16,178)
|
|
|
$(8,145)
|
|
|
$(38,002)
|
|
|
$(9,996)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Interest Expense, net, includes interest incurred on our various borrowing facilities and the amortization of debt issuance
costs.
|
|
(2)
|
Transaction and other related costs – For the three and six months ended June 30, 2024 (Predecessor), this is comprised of
consulting, legal, and other professional fees related to the Business Combination.
|
|
(3)
|
Change in fair value of financial liabilities – For the three and six months ended June 30, 2025 (Successor), the change in fair
value of financial liabilities primarily consists of the change in fair value of the warrant liability and the earnout liability. For the three and six months ended June 30, 2024 (Predecessor), this is comprised entirely of the change
in fair value of the embedded derivative associated with the convertible notes.
|
|
(4)
|
Stock based compensation – For the three and six months ended June 30, 2025 (Successor), stock based compensation primarily
consisted of awards in the 2024 Equity and Incentive Plan entered into on October 2, 2024 subsequent to the Business Combination. These awards consisted of Stock Options, Restricted Stock Units (“RSUs”), and Stock Appreciation Rights.
Further, a portion of this expense was related to share-based payment employee incentive plans in existence at Innventure LLC and other subsidiaries. Additional Stock Options were granted in February 2025 and additional RSUs were
granted in June 2025 which are included in the stock-based compensation caption for their respective periods. For the three and six months ended June 30, 2024 (Predecessor), stock-based compensation was comprised wholly of share-based
payment employee incentive plans in existence at Innventure LLC and other subsidiaries.
|
|
(5)
|
Goodwill impairment - For the three and six months ended June 30, 2025 (Successor), the Company recognized goodwill impairment
due to sustained decreases in the Company’s publicly quoted share price and market capitalization, which were, at least in part, sensitive to the general downward volatility experienced in the stock market from late February 2025
through April 2025. The publicly quoted share price stabilized some in May 2025 and June 2025. There was no similar goodwill impairment charge for the three and six months ended June 30, 2024 (Predecessor).
|
|
(6)
|
Loss on extinguishment of debt - For the three and six months ended June 30, 2025 (Successor), the Company modified the WTI
Facility, and such modification was accounted for as a debt extinguishment while no debt was repaid. There was no loss on extinguishment of debt for the three and six months ended June 30, 2024 (Predecessor).
|
|
(7)
|
Loss on extinguishment of related party debt - For the three and six months ended June 30, 2025 (Successor), the Company
extinguished certain related party debts by issuing Series C Preferred Stock. There was no loss on extinguishment of related party debt for the three and six months ended June 30, 2024 (Predecessor).
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
S/P Combined
(Non-GAAP)
|
|
|
Predecessor
|
|
|
Non-GAAP
|
|||
|
|
|
|
Period from
October 2,
2024
through
December 31,
2024
|
|
|
Period from
January 1,
2024
through
October 1,
2024
|
|
|
Year ended
December 31,
2024
|
|
|
Year ended
December 31,
2023
|
|
|
2024 vs 2023 Changes
|
|||
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
(%)
|
|
Revenue
|
|
|
456
|
|
|
764
|
|
|
1,220
|
|
|
1,117
|
|
|
103
|
|
|
9.2%
|
|
Operating Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
3,752
|
|
|
777
|
|
|
4,529
|
|
|
—
|
|
|
4,529
|
|
|
nil
|
|
General and administrative
|
|
|
29,652
|
|
|
26,608
|
|
|
56,260
|
|
|
17,589
|
|
|
38,671
|
|
|
219.9%
|
|
Sales and marketing
|
|
|
2,009
|
|
|
4,178
|
|
|
6,187
|
|
|
3,205
|
|
|
2,982
|
|
|
93.0%
|
|
Research and development
|
|
|
5,340
|
|
|
5,978
|
|
|
11,318
|
|
|
4,001
|
|
|
7,317
|
|
|
182.9%
|
|
Total Operating Expenses
|
|
|
40,753
|
|
|
37,541
|
|
|
78,294
|
|
|
24,795
|
|
|
53,499
|
|
|
215.8%
|
|
Loss from Operations
|
|
|
(40,297)
|
|
|
(36,777)
|
|
|
(77,074)
|
|
|
(23,678)
|
|
|
(53,396)
|
|
|
225.5%
|
|
Non-operating (Expense) and Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
(1,132)
|
|
|
(1,300)
|
|
|
(2,432)
|
|
|
(1,224)
|
|
|
(1,208)
|
|
|
98.7%
|
|
Net gain (loss) from investments
|
|
|
—
|
|
|
11,547
|
|
|
11,547
|
|
|
(6,448)
|
|
|
17,995
|
|
|
279.1%
|
|
Net (loss) gain on investments - due to related
parties
|
|
|
—
|
|
|
(468)
|
|
|
(468)
|
|
|
232
|
|
|
(700)
|
|
|
(301.7)%
|
|
Change in fair value of financial liabilities
|
|
|
(20,946)
|
|
|
(478)
|
|
|
(21,424)
|
|
|
766
|
|
|
(22,190)
|
|
|
(2,896.9)%
|
|
Equity method investment (loss) income
|
|
|
(902)
|
|
|
893
|
|
|
(9)
|
|
|
(632)
|
|
|
623
|
|
|
(98.6)%
|
|
Loss on conversion of promissory notes
|
|
|
—
|
|
|
(1,119)
|
|
|
(1,119)
|
|
|
—
|
|
|
(1,119)
|
|
|
nil
|
|
Write-off of loan commitment fee asset
|
|
|
(10,041)
|
|
|
—
|
|
|
(10,041)
|
|
|
—
|
|
|
(10,041)
|
|
|
nil
|
|
Miscellaneous other expense
|
|
|
(57)
|
|
|
(64)
|
|
|
(121)
|
|
|
—
|
|
|
(121)
|
|
|
nm*
|
|
Total Non-operating (Expense)
Income
|
|
|
(33,078)
|
|
|
9,011
|
|
|
(24,067)
|
|
|
(7,306)
|
|
|
(16,761)
|
|
|
229.4%
|
|
Income tax expense (benefit)
|
|
|
(3,282)
|
|
|
432
|
|
|
(2,850)
|
|
|
—
|
|
|
(2,850)
|
|
|
nm*
|
|
Net Loss
|
|
|
(70,093)
|
|
|
(28,198)
|
|
|
$(98,291)
|
|
|
(30,984)
|
|
|
(67,307)
|
|
|
217.2%
|
|
Less: net loss attributable to Non-redeemable
non-controlling interest
|
|
|
(8,339)
|
|
|
(11,762)
|
|
|
$(20,101)
|
|
|
(139)
|
|
|
(19,962)
|
|
|
14,361.2%
|
|
Net Loss Attributable to
Innventure, Inc. Stockholders / Innventure LLC Unitholders
|
|
|
(61,754)
|
|
|
(16,436)
|
|
|
(78,190)
|
|
|
(30,845)
|
|
|
(47,345)
|
|
|
153.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
S/P Combined
(Non-GAAP)
|
|
|
Predecessor
|
|
|
Non-GAAP
|
|||
|
|
|
|
Period from
October 2,
2024
through
December 31,
2024
|
|
|
Period from
January 1,
2024
through
October 1,
2024
|
|
|
Year ended
December 31,
2024
|
|
|
Year ended
December 31,
2023
|
|
|
2024 vs 2023 Changes
|
|||
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
(%)
|
|
Other comprehensive income, net of taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain on available-for-sale debt
securities - related party
|
|
|
909
|
|
|
62
|
|
|
971
|
|
|
—
|
|
|
971
|
|
|
nil
|
|
Total other comprehensive loss,
net of taxes
|
|
|
909
|
|
|
62
|
|
|
$971
|
|
|
—
|
|
|
971
|
|
|
nil
|
|
Total comprehensive loss, net of
taxes
|
|
|
(69,184)
|
|
|
(28,136)
|
|
|
(97,320)
|
|
|
(30,984)
|
|
|
(66,336)
|
|
|
214.1%
|
|
Less: comprehensive income attributable to
Non-redeemable non-controlling interest
|
|
|
(8,339)
|
|
|
(11,762)
|
|
|
(20,101)
|
|
|
(139)
|
|
|
(19,962)
|
|
|
14,361.2%
|
|
Net Comprehensive Loss
Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders
|
|
|
(60,845)
|
|
|
(16,374)
|
|
|
(77,219)
|
|
|
(30,845)
|
|
|
(46,374)
|
|
|
150.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
not meaningful
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
S/P Combined
(Non-GAAP)
|
|
|
Predecessor
|
|
|
|
|
Period from
October 2,
2024 through
December 31,
2024
|
|
|
Period from
January 1,
2024 through
October 1,
2024
|
|
|
Year ended
December 31,
2024
|
|
|
Year ended
December 31,
2023
|
|
Net Loss
|
|
|
(70,093)
|
|
|
(28,198)
|
|
|
(98,291)
|
|
|
(30,984)
|
|
Interest expense, net(1)
|
|
|
11,173
|
|
|
1,300
|
|
|
12,473
|
|
|
1,224
|
|
Depreciation and amortization expense
|
|
|
5,455
|
|
|
146
|
|
|
5,601
|
|
|
8
|
|
Provision for income taxes
|
|
|
3,282
|
|
|
(432)
|
|
|
2,850
|
|
|
—
|
|
EBITDA
|
|
|
(50,183)
|
|
|
(27,184)
|
|
|
(77,367)
|
|
|
(29,752)
|
|
Transaction and other related costs(2)
|
|
|
2,309
|
|
|
9,414
|
|
|
11,723
|
|
|
3,452
|
|
Change in fair value of financial liabilities(3)
|
|
|
20,946
|
|
|
478
|
|
|
21,424
|
|
|
(766)
|
|
Stock based compensation(4)
|
|
|
16,338
|
|
|
1,056
|
|
|
17,394
|
|
|
910
|
|
Adjusted EBITDA
|
|
|
(10,590)
|
|
|
(16,236)
|
|
|
(26,826)
|
|
|
(26,156)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Interest expense, net – For the combined twelve months ended December 31, 2024, interest expense, net includes interest incurred
on our various borrowing facilities and the amortization of debt issuance costs. Additional debt issuance cost associated with a loan commitment fee asset in the amount of $10,041 was written off in combined twelve months ended
December 31, 2024 and has also been included in this adjustment. This amount is representative of the asset associated with the second and third tranches of the WTI facility. When it became known that we would not be able to draw on
these subsequent tranches based on certain metrics contained within the WTI Facility agreement, we immediately wrote this asset off. For the Predecessor year ended December 31, 2023, this balance is comprised entirely of interest
incurred on our various borrowing facilities.
|
|
(2)
|
Transaction and other related costs – For the combined twelve months ended December 31, 2024 and for the Predecessor year ended
December 31, 2023 this is comprised entirely of consulting, legal, and other professional fees related to the “Business Combination”.
|
TABLE OF CONTENTS
|
(3)
|
Change in fair value of financial liabilities – For the combined twelve months ended December 31, 2024 the change in fair value
of financial liabilities primarily consists of the change in fair value of the warrant liability, change in fair value of the earnout liability, and the change in the fair value of the embedded derivative associated with convertible
notes prior to extinguishment. For the Predecessor year ended December 31, 2023, this is comprised entirely of the change in fair value of the embedded derivative associated with the convertible notes.
|
|
(4)
|
Stock based compensation – For the combined twelve months ended December 31, 2024 stock based compensation primarily consisted of
awards in the 2024 Equity and Incentive Compensation Plan entered into on October 2, 2024 subsequent to the Business Combination. These awards consisted of Stock Options, RSUs, and Stock Appreciation Rights. Further, a portion of this
expense was related to share based payment employee incentive plans in existence at Innventure LLC and other subsidiaries. For the Predecessor year ended December 31, 2023, stock based compensation was comprised wholly of share based
payment employee incentive plans in existence at Innventure LLC and other subsidiaries.
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2025
|
|
|
December 31, 2024
|
|
Cash and cash equivalents
|
|
|
$6,965
|
|
|
$11,119
|
|
Working capital
|
|
|
(51,188)
|
|
|
(45,061)
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
Change
|
|||
|
|
|
|
Six months
ended June
30, 2025
|
|
|
Six months
ended June
30, 2024
|
|
|
Amount
|
|
|
%
Change
|
|
Net Cash Used in Operating Activities
|
|
|
$(36,754)
|
|
|
$(16,391)
|
|
|
$(20,363)
|
|
|
124.2%
|
|
Net Cash Used in Investing Activities
|
|
|
(3,640)
|
|
|
(4,377)
|
|
|
737
|
|
|
(16.8)%
|
|
Net Cash Provided by Financing Activities.
|
|
|
41,240
|
|
|
20,274
|
|
|
20,966
|
|
|
103.4%
|
|
Net (Decrease) Increase in Cash,
Cash Equivalents and Restricted Cash
|
|
|
$846
|
|
|
$(494)
|
|
|
$1,340
|
|
|
271.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
S/P
Combined
2024
|
|
|
Predecessor
|
|
|
Change
|
|||
|
|
|
|
October 2,
2024
through
December 31,
2024
|
|
|
January 1,
2024
through
October 1,
2024
|
|
|
Year ended
December 31,
2024
|
|
|
Year ended
December 31,
2023
|
|
|
Amount
|
|
|
%
Change
|
|
Net Cash Used in Operating Activities
|
|
|
$(29,214)
|
|
|
$(18,848)
|
|
|
$(48,062)
|
|
|
$(19,476)
|
|
|
$(28,586)
|
|
|
146.8%
|
|
Net Cash Provided by (Used in) Investing Activities
|
|
|
6,822
|
|
|
(5,957)
|
|
|
865
|
|
|
(4,667)
|
|
|
5,532
|
|
|
118.5%
|
|
Net Cash Provided by Financing Activities
|
|
|
33,466
|
|
|
38,441
|
|
|
71,907
|
|
|
19,174
|
|
|
52,733
|
|
|
275.0%
|
|
Net Increase (Decrease) in Cash, Cash Equivalents
and Restricted Cash
|
|
|
$11,074
|
|
|
$13,636
|
|
|
$24,710
|
|
|
$(4,969)
|
|
|
$29,679
|
|
|
(597.3)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025
(remaining
6 months)
|
|
|
2026
|
|
|
2027
|
|
|
2028
|
|
|
Thereafter
|
|
|
Total
|
|
Operating lease
|
|
|
$309
|
|
|
$693
|
|
|
$467
|
|
|
$228
|
|
|
$—
|
|
|
$1,697
|
|
Debt obligations
|
|
|
13,011
|
|
|
29,234
|
|
|
8,244
|
|
|
4,561
|
|
|
—
|
|
|
55,050
|
|
Fixed future installments payable
|
|
|
700
|
|
|
825
|
|
|
825
|
|
|
825
|
|
|
9,900
|
|
|
13,075
|
|
Total
|
|
|
$14,020
|
|
|
$30,752
|
|
|
$9,536
|
|
|
$5,614
|
|
|
$9,900
|
|
|
$69,822
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS

TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
Access Advantage: The relationship with an MNC provides unique access to MNC
technologies and/or the information needed to help Innventure evaluate a disruptive technology solution in the context of specific unmet market needs. Using both data from the MNC and its own evaluations, Innventure determines if the
opportunity should progress to a new Innventure Company.
|
|
•
|
Developed Technology Solutions: MNCs invest significant time, money, and technical
expertise in developing and protecting innovative technology solutions that satisfy unmet market needs for them and their customers. This all occurs well before Innventure acquires the technology solution. A new Innventure Company that
sources the technology solution from an MNC—including IP such as patents and trade secrets, product prototypes, manufacturing equipment, and other assets—has access to the MNC’s technical expertise for transfer and early
industrialization of the technology, all of which helps reduce commercialization time, save money, and mitigate common risks inherent to start-ups.
|
|
•
|
Institutional Data Set: MNCs also spend significant time and money developing deep,
proprietary market knowledge, which is very difficult for a typical new venture to replicate. MNCs are in a position to provide Innventure with highly robust data, including market insights and customer testing, to understand unmet
market needs and to assess the technology solution and potential business models.
|
|
•
|
Early Customer Adoption: We believe MNCs with which we collaborate will be motivated to
catalyze market adoption of a technology solution by becoming early customers and/or providing channel access to facilitate the initial customer base to drive financial and strategic value. When Innventure sources technology from an
entity that is not expected to be a channel partner, it seeks to establish a relationship with an MNC that will serve as a channel partner for the new company. In some cases, MNCs may choose to sign offtake agreements with the new
company and/or facilitate access to prospective customers within their sphere of influence (e.g., suppliers or customers). We believe when an MNC is the original “inventor” or an early adopter of the technology solution, it may bring
immediate credibility to the new Innventure Company which can lead to greater interest from potential customers.
|
TABLE OF CONTENTS
|
•
|
PureCycle: Purifies and recycles post-industrial and post-consumer polypropylene waste
back to a like virgin grade polymer, usable across a broad range of applications and markets. PureCycle became a publicly traded company in 2021 and, as of the date of this prospectus, Innventure no longer has an economic interest in
PureCycle.
|
|
•
|
AeroFlexx: Combines the best attributes of flexible pouches and rigid bottles to
provide consumer packaged goods (“CPG”) companies with a novel, curbside recyclable primarily liquid package that uses up to 85% less virgin plastic than standard rigid bottles, significantly simplifies packaging supply
|
TABLE OF CONTENTS
|
•
|
Accelsius: Delivers a transformative industry solution to thermal management to central
processing units (“CPUs”) and graphics processing units (“GPUs”) in datacenter and telecommunications applications, with potential to allow operators to increase computational throughput and capacity, increase revenue, reduce operating
costs, increase energy efficiency, and drive sustainability across server, switching, and edge computing environments. Accelsius is an early-stage company that is just beginning revenue-generating operations. Accelsius has been focused
on developing and commercializing data center cooling products since its inception in 2022 and has begun generating revenue.
|
|
•
|
Refinity: Intends to commercialize process technologies for converting low cost,
abundant plastic waste to drop-in chemicals directly useful in and consumable by the existing petrochemical supply chain.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
an exponential predicted increase in the thermal footprint, or thermal design power (“TDP”), of server and GPU chipsets which
are now beginning to exceed the capability of the incumbent refrigerated-air cooling systems;
|
|
•
|
increased and unpredictable global energy costs; and
|
|
•
|
an increased level of commitment to environmental sustainability, including from C-suites and corporate management teams.
|
|
•
|
Components: Increased software stack (including AI) require higher performance
processors which increase heat dissipation.
|
|
•
|
Equipment: More powerful servers, routers, switches, cell tower base stations, and
other computing equipment require improved system level cooling.
|
|
•
|
Systems: Denser racks of equipment are dissipating more heat per unit area.
|
|
•
|
Facilities: Heat management capacity of data center and telecom facilities are pushing
the limits of current air cooling technologies.
|
|
•
|
Growth: There are currently 4.1 GW of new data centers planned.
|
TABLE OF CONTENTS
|
•
|
Total Cost of Ownership Savings: Cooling accounts for approximately 40% of a data
center’s energy consumption.
|
|
•
|
Space Savings: Accelsius allows data centers to densify, increasing the number of
servers per rack, increasing the number of racks per unit area of data center, and increasing revenue for a given data center footprint and reducing costs as less space is used.
|
|
•
|
Energy Savings: Eliminates air conditioning needs and costs associated with legacy
air-cooling systems.
|
|
•
|
Water Savings: Potential to eliminate water use in cooling system.
|
|
•
|
Enables the adoption of high wattage processors. The American Society of Heating,
Refrigerating and Air-Conditioning Engineers has suggested that the exponential increase of CPU and GPU wattages is expected to soon exceed the capacity of most existing air cooling systems.
|
|
•
|
Dramatically improves density in the data center. With Accelsius’ technology, air heat
syncs are not required, allowing more processing power in each server. Racks no longer must be depopulated to allow air flow, nor are cold and hot aisles needed.
|
|
•
|
Allows more power to be allocated to computing rather than cooling. An average data
center allocates around 40% of their power to cooling and other overhead. When power used for cooling is reduced, more incoming power for data centers can be used for computing tasks, and data center capacity can be increased
dramatically. We estimate that we can reduce the power allocated to cooling by around 49%.
|
|
•
|
Is compatible with legacy infrastructure. Although new data center builds will
prioritize liquid cooling, brownfield sites are still actively introducing AI / machine learning and other dense workloads. Accelsius technology can fit in a standard rack and connect to existing facility water loops.
|
|
•
|
Heat removal head room. We believe Accelsius technology will be designed to support not
just this generation of processors, but many more to come. Standard CPU power consumption is expected to exceed 500 W and standard GPU power consumption is expected to exceed 700 W by the end of 2025, with high performance GPUs reaching
2000 watts in 2026. Based on the recent trajectory of increasing CPU and GPU power consumption, we believe there is a high likelihood that chips may reach temperatures of up to 2500 watts in the near future. The ability to cool these
power processors helps protect the investment in Accelsius’ NeuCool technology.
|
TABLE OF CONTENTS
|
•
|
Expensive (~$100,000 per tank) and with limited thermal headroom (< 50 KW);
|
|
•
|
Requires modification (re-layout) of server internals for liquid flow and server warranty is usually void;
|
|
•
|
Servicing requires removal of servers from sealed liquid cooling baths and is time consuming and expensive;
|
TABLE OF CONTENTS
|
•
|
Forklift upgrade of existing rack infrastructure and inefficient use of real estate; and
|
|
•
|
Leading competitors include LiquidStack, Green Revolution Cooling, and TMGCore.
|
|
•
|
Very expensive (~$175,000 per tank);
|
|
•
|
Vapor can get trapped in the servers causing localized hot spots;
|
|
•
|
Very few pilot implementations are expanded on because “no one wants tanks full of perfluoroalkyl and polyfluoroalkyl substances
coolant in the data center;” and
|
|
•
|
Leading competitors include LiquidStack, TMGCore and Submer.
|
|
•
|
Water leaks that can cause catastrophic failure in servers and are the most significant risk. Users state that water leaks
around electronic components have occurred and destroyed the servers: “Not a question of ‘if’ it will leak, but ‘when’ it will leak”;
|
|
•
|
Bio-fouling (biofilm build up) within pipes and cold plates is a concern;
|
|
•
|
Cooling higher thermal densities requires large pumps and high pressure/flow rate of water (increasing chance of leaks &
electricity use); and
|
|
•
|
Leading competitors include CoolIT Systems and STULZ.
|
|
3
|
Not recyclable in all communities. Check locally.
|
TABLE OF CONTENTS
|
•
|
Package Circularity: AeroFlexx packaging can incorporate up to 50% recycled content
without compromise.
|
|
•
|
Life Cycle Analysis: By considering source reduction, recycled content, recyclability
and eliminating excess packaging material in e-commerce, AeroFlexx can deliver up to 83% less waste to landfills, 69% GHG reduction, and 73% less water use.
|
|
•
|
UN Sustainable Goals Alignment: AeroFlexx can contribute to meeting several of the
sustainable development goals outlined by the United Nations, including industry, innovation, and infrastructure; responsible consumption and production; climate action; and life below water.
|
|
•
|
GHG emissions reduction relative to plastic waste incineration or pyrolysis: Internal
LCA analysis indicated about - 400 kg CO2-eq/tonne plastic waste for the Refinity fluidized bed conversion process compared to 1777 kg CO2-eq/tonne plastic waste for incineration and 739 kg CO2-eq/tonne plastic waste for pyrolysis, so
Refinity believes that its process will reduce GHG emissions.
|
TABLE OF CONTENTS
|
•
|
Fossil source reduction: If all plastic waste from landfill and incineration
(240 million tonnes per year) were converted to hydrocarbon liquids (e.g., naphtha substitute) at yields consistent with what Refinity believes are possible in the fluidized bed process, those hydrocarbon liquids could replace up to 80%
of fossil naphtha; saving roughly 96 million tonnes per year of CO2-eq emissions.
|
|
•
|
Reduces Complexity of Sourcing: AeroFlexx ships as a flat pak and replaces the bottle,
cap and label that customers must procure from multiple sources and destinations.
|
|
•
|
Reduced Transportation Cost and Footprint: prior to filling the package, shipping as a
flat pak creates a form factor that takes up less than 10% of the space in shipping of an equivalent pre-formed empty rigid bottle, in addition to eliminating the need for cap and label supply chains. This reduces cost and environmental
footprint by taking trucks off the road.
|
|
•
|
Lowers Warehouse Requirements and Inventory Cost: with the AeroFlexx flat pak replacing
pre-formed empty bottles, caps and labels, there is an overall reduction in the need for inventory space and overall cost associated with labor and working capital.
|
|
•
|
ISTA-6 Amazon Approved: for shipping liquids via the e-commerce channel, reductions in
damages from breakage, leakage and handling can generate significant savings through lower returns or refund rates and reduced overall package and labor costs.
|
|
•
|
Omni-Channel Ready: the pak is omni-channel ready as soon as it is filled with liquid
product from the AeroFlexx filling machine, which we expect to eliminate stock keeping unit proliferation based on desired sales distribution channel.
|
|
•
|
New Size/Shape Development Efficiency: flexible manufacturing eliminates the need for
capital intensive molds and tooling costs, which may enable rapid adoption at a much lower cost.
|
|
•
|
Product Safety: designed with hygiene in mind with tamper proof packaging that
eliminates the use of a discrete closure with AeroFlexx proprietary integrated valve (e.g., no need for a separate cap, pump or package sealing and dispensing device) to help keep products safe and prevent product losses.
|
|
•
|
Enable higher yield conversion of plastic waste to olefin gases and hydrocarbon liquids.
VTT has demonstrated that the fluidized bed process converts plastic waste to olefin gases at higher yield than conventional pyrolysis processes, potentially enabling two to three times higher productivity when the fluidized bed process
feeds olefin gases directly to petrochemical steam cracker operations.
|
|
•
|
Allow use of low cost, mixed plastic wastes. Unlike incumbent recycling processes which
typically require more sorting and pre-cleaning of plastic wastes, Refinity believes that the fluidized bed process will be more robust to minimally-sorted, mixed plastic waste streams.
|
|
•
|
Enable plant site flexibility. We believe that the Refinity fluidized bed operating
conditions can be tuned to allow for production of either olefin (ethylene and propylene) gases and hydrocarbon liquids. We believe the flexibility to site and build a liquids plant close to low-cost plastic waste feedstock sources will
allow Refinity to minimize transportation costs for plastic waste and reduce operating costs. Refinity expects to site an olefin gas plant adjacent to petrochemical steam cracker operations to take advantage of existing site
infrastructure and product purification while also minimizing cost for transporting the olefin product.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
our Class II directors are David Yablunosky, James O. Donnally and Bruce Brown, and their terms will expire at the annual
meeting of stockholders to be held in 2026;
|
|
•
|
our Class III directors are Michael Otworth, Suzanne Niemeyer and Elizabeth Williams, and their terms expire at the annual
meeting of stockholders to be held in 2027; and
|
|
•
|
our Class I directors are Gregory W. Haskell, Daniel J. Hennessy and Michael Amalfitano, and their terms will expire at the
annual meeting of stockholders to be held in 2028.
|
TABLE OF CONTENTS
|
•
|
up to seven (7) directors, so long as the Founding Investors beneficially own greater than 70% of the outstanding shares of
Common Stock;
|
|
•
|
up to six (6) directors, so long as the Founding Investors beneficially own more than 50%, but less than 70%, of the outstanding
shares of Common Stock;
|
|
•
|
up to four (4) directors, so long as the Founding Investors beneficially own at least 40%, but less than 50%, of the outstanding
shares of Common Stock;
|
|
•
|
up to three (3) directors, so long as the Founding Investors beneficially own at least 20%, but less than 40%, of the
outstanding shares of Common Stock; and
|
|
•
|
up to two (2) director, so long as the Founding Investors beneficially own at least 5%, but less than 20%, of the outstanding
common shares of the Company.
|
TABLE OF CONTENTS
|
|
|||||||||||||||||||||||||||
|
Committee Assignments
|
|||||||||||||||||||||||||||
|
|
|
|
Donnally
|
|
|
Brown
|
|
|
Williams
|
|
|
Hennessy
|
|
|
Amalfitano
|
|
|
Haskell*
|
|
|
Yablunosky*
|
|
|
Otworth*
|
|
|
Niemeyer*
|
|
Audit
|
|
|
C
|
|
|
|
|
|
X
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation
|
|
|
X
|
|
|
C
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N&CG
|
|
|
|
|
|
X
|
|
|
X
|
|
|
|
|
|
C
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
Not independent
|
TABLE OF CONTENTS
|
•
|
Gregory W. (Bill) Haskell, Chief Executive Officer and Manager;
|
|
•
|
Mike Otworth, Executive Chairman; and
|
|
•
|
Dr. John Scott, Chief Strategy Officer.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name and Principal Position
|
|
|
Fiscal
Year
|
|
|
Salary
($)(1)
|
|
|
Bonus
($)(2)
|
|
|
Stock
Awards
($)(3)
|
|
|
Option
Awards
($)(4)
|
|
|
Non-Equity
Incentive Plan
Compensation
($)
|
|
|
All Other
Compensation
($)(5)
|
|
|
Total
($)
|
|
Gregory W. (Bill) Haskell
|
|
|
2024
|
|
|
300,000
|
|
|
2,500,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,800
|
|
|
2,813,800
|
|
Chief Executive Officer
|
|
|
2023
|
|
|
300,000
|
|
|
180,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,000
|
|
|
492,000
|
|
Mike Otworth
|
|
|
2024
|
|
|
300,000
|
|
|
—
|
|
|
7,001,001
|
|
|
7,577,786
|
|
|
—
|
|
|
—
|
|
|
14,878,787
|
|
Executive Chairman(6)
|
|
|
2023
|
|
|
300,000
|
|
|
180,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
480,000
|
|
Dr. John Scott
|
|
|
2024
|
|
|
300,000
|
|
|
—
|
|
|
4,100,005
|
|
|
6,935,489
|
|
|
—
|
|
|
—
|
|
|
11,335,494
|
|
Chief Strategy Officer(7)
|
|
|
2023
|
|
|
300,000
|
|
|
180,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
480,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The amount in this column for 2024 for Mr. Haskell represents base salary earned during 2024. For Dr. Scott, the amount
represents payments to Corporate Development Group LLC (a company 100% owned by Dr. Scott) with respect to Dr. Scott’s consulting services to Innventure during 2024. For Mr. Otworth, the amount in this column for 2024 represents
payments to Sugar Grove Ventures, LLC (a company 100% owned by Mr. Otworth) with respect to Mr. Otworth’s consulting services to Innventure for 2024.
|
|
(2)
|
The amount in this column for Mr. Haskell in 2024 represents a transaction bonus earned in connection with the Business
Combination.
|
|
(3)
|
The amounts in this column reflect the aggregate grant date fair value of service-based RSUs granted by the Company to the NEOs
in 2024 and, with respect to Mr. Otworth, the amount includes the aggregate grant date fair value of the Accelsius Incentive Units (as defined below) granted by Accelsius to him in 2024, each calculated in accordance with Financial
Accounting Standards Board Accounting Standards Codification (“FASB ASC”) Topic 718. For information regarding the assumptions used in calculating the value of these awards, see Note 14 to the consolidated financial statements included
elsewhere in this prospectus. For more information regarding the awards disclosed in this column, see “2024 Equity-Based Compensation” below. The Refinity Incentive Units (as defined below) discussed in such section had an aggregate
grant date fair value of $0.
|
|
(4)
|
The amounts in this column reflect the aggregate grant date fair values of option awards and stock appreciation right awards
(“SARs”) granted by the Company to the NEOs in 2024, each calculated in accordance with FASB ASC Topic 718. For information regarding the assumptions used in calculating the value of these awards, see Note 14 to the consolidated
financial statements included elsewhere in this prospectus. For more information regarding the awards disclosed in this column, see “2024 Equity-Based Compensation” below.
|
TABLE OF CONTENTS
|
(5)
|
The amount in this column represents matching contributions provided by Innventure under the 401(k) Plan (as defined and
described below).
|
|
(6)
|
Mr. Otworth provided services to Innventure in a consulting capacity during 2024 through a contract between Innventure LLC and
Sugar Grove Ventures, LLC.
|
|
(7)
|
Dr. Scott provided services to Innventure in a consulting capacity during 2024 through a contract between Innventure LLC and
Corporate Development Group LLC, pursuant to which Dr. Scott, the founder and principal of Corporate Development Group LLC, provided strategic guidance and consulting services to Innventure.
|
|
|
|
|
|
|
NEO
|
|
|
2024 Base
Salary/Service Fee
Rate
|
|
Gregory Haskell
|
|
|
$300,000
|
|
Mike Otworth
|
|
|
$300,000
|
|
Dr. John Scott
|
|
|
$300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2024 Bonus Goal
|
|
|
Weighting
|
|
|
Goal
Achieved?
(yes or no)
|
|
Formation of a new (4th) operating company
|
|
|
25%
|
|
|
Yes
|
|
Complete the Business Combination with more than $20 million of net
proceeds
|
|
|
50%
|
|
|
Yes
|
|
Meeting each of the following milestones (or a achieving a certain
threshold share price):
|
|
|
|
|
|
|
|
•
Formation of a new (4th) operating company
|
|
|
10%
|
|
|
Yes
|
|
•
$10 million of booked revenue for Accelsius
|
|
|
10%
|
|
|
No
|
|
•
$15 million of GAAP revenue for AeroFlexx
|
|
|
5%
|
|
|
No
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
NEO
|
|
|
RSUs
|
|
|
Options*
|
|
Gregory Haskell
|
|
|
—
|
|
|
—
|
|
Mike Otworth
|
|
|
537,705
|
|
|
262,295
|
|
Dr. John Scott
|
|
|
336,066
|
|
|
163,934
|
|
|
|
|
|
|
|
|
|
*
|
The options set forth in the table above were granted with an exercise price of $12.20, the closing stock price on the date of
grant.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
|
Grant Date
|
|
|
Number of
securities
underlying the
award
|
|
|
Exercise price
of the award
($/Sh)
|
|
|
Grant date fair
value of the
award
|
|
|
Percentage change in
the closing market price
of the securities
underlying the award
between the trading day
ending immediately
prior to the disclosure of
material nonpublic
information and the
trading day beginning
immediately following
the disclosure of
material nonpublic
information
|
|
Gregory Haskell, CEO
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Mike Otworth, Executive Chairman
|
|
|
12/9/2024
|
|
|
262,295
|
|
|
12.20
|
|
|
$1,712,786
|
|
|
(0.88)%
|
|
Dr. John Scott, Chief Strategy Officer
|
|
|
12/9/2024
|
|
|
163,934
|
|
|
12.20
|
|
|
$1,070,489
|
|
|
(0.88)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Name
|
|
|
Type of Award(1)
|
|
|
Option Awards
|
|
|
Stock Awards
|
||||||||||||
|
|
Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
|
|
|
Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
|
|
|
Option
Exercise
Price
($)
|
|
|
Option
Expiration
Date
|
|
|
Number of
Shares or
Units of Stock
That Have
Not Vested (#)
|
|
|
Market Value
of Shares or
Units of Stock
That Have
Not Vested
($)
|
|||||
|
Gregory W. (Bill) Haskell
|
|
|
Refinity Units
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
109,000(4)
|
|
|
—
|
|
Mike Otworth
|
|
|
INV Options
|
|
|
—
|
|
|
262,295(2)
|
|
|
12.20
|
|
|
12/9/2034
|
|
|
|
|
|
|
|
|
Refinity Units
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
109,000(4)
|
|
|
—
|
||
|
|
Accelsius SARs
|
|
|
—
|
|
|
150,000(3)
|
|
|
12.175
|
|
|
12/31/2026
|
|
|
|
|
|
|
||
|
|
INV RSUs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
537,705(5)
|
|
|
7,447,214
|
||
|
|
Accelsius Units
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
75,000(6)
|
|
|
3,147,750(7)
|
||
|
Dr. John Scott
|
|
|
INV Options
|
|
|
—
|
|
|
163,934(2)
|
|
|
12.20
|
|
|
12/9/2034
|
|
|
|
|
|
|
|
|
Refinity Units
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
109,000(4)
|
|
|
—
|
||
|
|
Accelsius SARs
|
|
|
—
|
|
|
150,000(3)
|
|
|
12.175
|
|
|
12/31/2026
|
|
|
|
|
|
|
||
|
|
INV RSUs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
336,066(5)
|
|
|
4,654,514
|
||
|
|
Accelsius Units
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,375(8)
|
|
|
434,813(7)
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Type of Award: Refinity Units – Refinity Incentive Units; INV Options – stock options to purchase shares of Common Stock;
INV RSUs – RSUs settled in shares of Common Stock; Accelsius SARs – awards granted by Innventure and settled in shares of Common Stock, the value of which is determined based on the increase in value of Class A Common Units of
Accelsius; Accelsius Units – Accelsius Incentive Units.
|
|
(2)
|
These stock options vested on October 2, 2025.
|
|
(3)
|
In general, these Accelsius SARs will be automatically exercised upon the earliest to occur of: (i) the 24-month anniversary of
the grant date, (ii) the participant’s death, or (iii) the participant’s “disability” (as defined in the applicable award agreement).
|
|
(4)
|
On December 11, 2024, Refinity Holdings granted to each NEO 109,000 Refinity Incentive Units, with a Refinity Distribution
Threshold of $0.00. Such Refinity Incentive Units will vest over a three-year period, with 25% vesting on the one-year anniversary of the grant date and 9.375% vesting quarterly thereafter.
|
|
(5)
|
These RSUs vested on October 2, 2025.
|
|
(6)
|
On March 22, 2024, Accelsius granted to Mr. Otworth 100,000 Accelsius Incentive Units, with an Accelsius Distribution Threshold
of $4.41. In general, these Accelsius Incentive Units were originally scheduled to vest over a three-year period, with 25% vesting on the grant date and 9.375% vesting quarterly beginning on the one-year anniversary of the grant date,
subject to Mr. Otworth’s continued service to Accelsius or one of its subsidiaries. However, as noted above, on August 11, 2025, each of the Compensation Committee and the Accelsius board of directors approved the acceleration and
vesting of the then-unvested portion of Mr. Otworth’s Accelsius Incentive Units effective as of August 14, 2025.
|
|
(7)
|
Because Accelsius was not publicly traded during 2024, these amounts represent the estimated market value of the unvested
Accelsius Incentive Units held by each of the NEOs as of December 31, 2024, as more fully described above under the heading “2024 Equity-Based Compensation,” based on an external valuation dated as of December 31, 2024.
|
|
(8)
|
On May 5, 2022, Accelsius granted to Dr. Scott 100,000 Accelsius Incentive Units, with an Accelsius Distribution Threshold of
$0.00. Such Accelsius Incentive Units were 25% vested on the date of grant, and the remainder of the Accelsius Incentive Units vest in eight substantially equal quarterly installments beginning 12 months after the date of grant. For a
discussion of the treatment of the NEOs’ Incentive Units in the Business Combination, see “Incentive Units Granted in Prior Years” above.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
Initial Equity Grant: Each non-management director that became a member of our Board as
of the Closing Date and who was still serving on our Board on the third business day following the effective date of the Director Compensation Plan received RSUs with a targeted value of $90,000 on such date, in respect of their service
from the Closing and the date of the Company’s first annual meeting of stockholders. Such RSUs vested on the date of our 2025 annual meeting of stockholders, subject to each non-management director providing service on our Board through
such date.
|
|
•
|
Quarterly cash retainer: Each non-management director will receive an annual cash
retainer fee of $80,000, paid in arrears on a quarterly basis. The annual cash retainer fee will be prorated in the event that a non-management director serves on our Board for a portion of any calendar quarter.
|
|
•
|
Annual equity retainer: On the date of each of our regularly scheduled annual meetings
of stockholders, each non-management director will receive a grant of RSUs with a targeted value of $120,000, which will generally vest on the earlier of (i) the first anniversary of the grant date and (ii) the next annual meeting of
stockholders that occurs following the grant date, subject to each non-management director providing service on our Board on such vesting date. If a non-management director is elected to our Board other than in connection with an annual
meeting of stockholders, such non-management director’s annual equity retainer will be prorated based on the number of days of service until the scheduled date of the next annual meeting of stockholders.
|
|
•
|
Committee retainers: Each non-management director who serves as the chairperson of a
standing committee of our Board will receive an annual cash retainer fee of $20,000, paid in arrears on a quarterly basis and prorated in the event that such non-management director serves in such position for a portion of any calendar
quarter. Each non-management director who serves as a member, but not a chairperson, of a committee of our Board will receive an annual cash retainer fee of $10,000 for each committee, paid in arrears on a quarterly basis and prorated
in the event that such non-management director serves in such position for a portion of any calendar quarter.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
|
Fees earned or
paid in cash
($)
|
|
|
Stock
awards ($)(1)
|
|
|
Option
awards
($)(2)
|
|
|
Total
($)
|
|
James Donnally
|
|
|
27,500
|
|
|
89,999
|
|
|
782,000
|
|
|
899,499
|
|
Bruce Brown
|
|
|
27,500
|
|
|
89,999
|
|
|
—
|
|
|
117,499
|
|
Elizabeth Williams
|
|
|
25,000
|
|
|
89,999
|
|
|
—
|
|
|
114,999
|
|
Daniel Hennessy
|
|
|
25,000
|
|
|
89,999
|
|
|
—
|
|
|
114,999
|
|
Michael Amalfitano
|
|
|
25,000
|
|
|
89,999
|
|
|
—
|
|
|
114,999
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Reflects the grant date fair value of the RSUs, calculated in accordance with FASB ASC Topic 718. For information regarding
assumptions used in calculating these values, see Note 14 to the consolidated financial statements included elsewhere in this prospectus. As of December 31, 2024, the non-management directors held the following outstanding stock awards:
each of Messrs. Donnally, Brown, Hennessy and Amalfitano and Ms. Williams, 7,377 RSUs.
|
|
(2)
|
Reflects the grant date fair value of the Accelsius SARs, calculated in accordance with FASB ASC Topic 718. For information
regarding assumptions used in calculating these values, see Note 14 to the consolidated financial statements included elsewhere in this prospectus. The Accelsius SARs were granted by Innventure and are settled in shares of Common Stock,
the value of which is determined based on the increase in value of Class A Common Units of Accelsius over a base price of $12.175. In general, these Accelsius SARs will be automatically exercised upon the earliest to occur of: (i) the
24-month anniversary of the grant date, (ii) Mr. Donnally’s death, or (iii) Mr. Donnally’s “disability” (as defined in the applicable award agreement). On June 25, 2025, Mr. Donnally entered into a SAR Amendment on substantially the
same terms as those described above that apply to Mr. Otworth and Dr. Scott, except that the Share Cap applicable to Mr. Donnally’s Accelsius SARs is 250,000. As of December 31, 2024, Mr. Donnally held 20,000 Accelsius SARs.
Mr. Donnally was granted these Accelsius SARs in respect of prior service.
|
TABLE OF CONTENTS
|
•
|
the amount involved exceeded or exceeds $120; and
|
|
•
|
any of such company’s directors, executive officers, or holders of more than 5% of its capital stock, or any immediate family
member of, or person sharing the household with, any of these individuals, had or will have a direct or indirect material interest.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|||
|
Company Name
|
|
|
Fiscal Year Ended
December 31,
|
|||
|
|
|
|
2024
|
|
|
2023
|
|
Accelsius
|
|
|
$126
|
|
|
160
|
|
AeroFlexx
|
|
|
*
|
|
|
*
|
|
ESG Fund
|
|
|
*
|
|
|
*
|
|
Refinity
|
|
|
$539
|
|
|
*
|
|
|
|
|
|
|
|
|
|
*
|
Less than $120
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
the Audit Committee shall review the material facts of all related party transactions;
|
|
•
|
in reviewing any related party transaction, the Audit Committee will take into account, among other factors that it deems
appropriate, whether the related party transaction is on terms no less favorable to Innventure than terms generally available in a transaction with an unaffiliated third-party under the same or similar circumstances and the extent of
the related party’s interest in the transaction;
|
|
•
|
in connection with its review of any related party transaction, Innventure shall provide the Audit Committee with all material
information regarding such related party transaction, the interest of the related party and any potential disclosure obligations of Innventure in connection with such related party transaction; and
|
|
•
|
if a related party transaction will be ongoing, the Audit Committee may establish guidelines for Innventure’s management to
follow in its ongoing dealings with the related party.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
the number of shares of any series and the designation to distinguish the shares of such series from the shares of all other
series;
|
|
•
|
the voting powers, if any, and whether such voting powers are full or limited in such series;
|
|
•
|
the redemption provisions, if any, applicable to such series, including the redemption price or prices to be paid;
|
|
•
|
whether dividends, if any, will be cumulative or noncumulative, the dividend rate of such series, and the dates and preferences
of dividends on such series;
|
|
•
|
the rights of such series upon the voluntary or involuntary dissolution of, or upon any distribution of the assets of, the
Company;
|
TABLE OF CONTENTS
|
•
|
the provisions, if any, pursuant to which the shares of such series are convertible into, or exchangeable for, shares of any
other class or classes or of any other series of the same or any other class or classes of stock, or any other security, of the Company or any other corporation or other entity, and the rates or other determinants of conversion or
exchange applicable thereto;
|
|
•
|
the right, if any, to subscribe for or to purchase any securities of the Company or any other corporation or other entity;
|
|
•
|
the provisions, if any, of a sinking fund applicable to such series;
|
|
•
|
any other relative, participating, optional, or other special powers, preferences or rights and qualifications, limitations, or
restrictions thereof; and
|
|
•
|
all as may be determined from time to time by the Board and stated or expressed in the resolution or resolutions providing for
the issuance of such preferred stock (collectively, a “Preferred Stock Designation”).
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
a director or officer for any breach of their duty of loyalty to our company or our stockholder;
|
|
•
|
a director or officer for any act or omission not in good faith or that involves intentional misconduct or a knowing violation
of law;
|
|
•
|
a director for unlawful payments of dividends or unlawful stock repurchases, or redemptions as provided in Section 174 of the
DGCL;
|
|
•
|
a director or officer for any transaction from which they derived an improper personal benefit; or
|
|
•
|
an officer in any action by or in the right of Innventure.
|
TABLE OF CONTENTS
|
•
|
each person known to us to be the beneficial owner of more than 5% of our Common Stock, Series B Preferred Stock, and Series C
Preferred Stock;
|
|
•
|
each of our NEOs and directors; and
|
|
•
|
all of our executive officers and directors as a group.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name and Address of Beneficial
Owner
|
|
|
Amount of
Common
Stock
Beneficially
Owned
|
|
|
Percentage
of Shares of
Common
Stock
|
|
|
Amount of
Series B
Preferred
Stock
Beneficially
Owned
|
|
|
Percentage
of Shares of
Series B
Preferred
Stock
|
|
|
Amount of
Series C
Preferred
Stock
Beneficially
Owned
|
|
|
Percentage of
Shares of
Series C
Preferred
Stock
|
|
Directors and
Named Executive Officers:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Roland Austrup
|
|
|
863,264
|
|
|
1.49%
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
James O. Donnally(1)
|
|
|
4,236,663
|
|
|
7.30%
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
Gregory W. Haskell
|
|
|
752,115
|
|
|
1.30%
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
Michael Otworth(2)
|
|
|
3,742,902
|
|
|
6.45%
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
John Scott(3)
|
|
|
2,581,653
|
|
|
4.45%
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
David Yablunosky
|
|
|
173,964
|
|
|
*
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
Suzanne Niemeyer
|
|
|
141,098
|
|
|
*
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
Bruce Brown
|
|
|
12,127
|
|
|
*
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
Elizabeth Williams
|
|
|
7,377
|
|
|
*
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
Daniel J. Hennessy
|
|
|
1,177,639
|
|
|
2.03%
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
Michael Amalfitano
|
|
|
7,377
|
|
|
*
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
All Directors
and Executive Officers as a Group (11 Individuals)
|
|
|
13,691,429
|
|
|
23.59%
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
Five Percent Holders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WE-INN LLC(4)
|
|
|
9,235,795
|
|
|
15.91%
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
Ascent Capital Partners LLC(5)
|
|
|
5,282,828
|
|
|
9.10%
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name and Address of Beneficial
Owner
|
|
|
Amount of
Common
Stock
Beneficially
Owned
|
|
|
Percentage
of Shares of
Common
Stock
|
|
|
Amount of
Series B
Preferred
Stock
Beneficially
Owned
|
|
|
Percentage
of Shares of
Series B
Preferred
Stock
|
|
|
Amount of
Series C
Preferred
Stock
Beneficially
Owned
|
|
|
Percentage of
Shares of
Series C
Preferred
Stock
|
|
CastleKnight Master Fund LP(6)
|
|
|
3,086,416
|
|
|
5.32%
|
|
|
—
|
|
|
|
|
|
—
|
|
|
*
|
|
Christopher and Donna Corley(7)
|
|
|
20,396
|
|
|
*
|
|
|
10,198
|
|
|
30.77%
|
|
|
—
|
|
|
*
|
|
Dr. Chi Lim(8)
|
|
|
10,198
|
|
|
*
|
|
|
5,099
|
|
|
15.38%
|
|
|
—
|
|
|
*
|
|
Crown Global Life Insurance LTD IRO Separate Account
30286(9)
|
|
|
100,000
|
|
|
*
|
|
|
—
|
|
|
*
|
|
|
50,000
|
|
|
33.33%
|
|
Glockner Family Venture Fund, LP(10)
|
|
|
4,680,272
|
|
|
8.06%
|
|
|
—
|
|
|
*
|
|
|
—
|
|
|
*
|
|
Javid Mu’az Baksh Living Trust(11)
|
|
|
20,396
|
|
|
*
|
|
|
10,198
|
|
|
30.77%
|
|
|
—
|
|
|
*
|
|
Matthew and Holly Sellers(12)
|
|
|
15,298
|
|
|
*
|
|
|
7,649
|
|
|
23.08%
|
|
|
—
|
|
|
*
|
|
Neil Eichelberger 2021 Irrevocable Trust(13)
|
|
|
200,000
|
|
|
*
|
|
|
—
|
|
|
*
|
|
|
100,000
|
|
|
66.67%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
less than 1%
|
|
(1)
|
Consists of (i) 4,750 shares of Common Stock held by Mr. Donnally; (ii) 1,507,808 shares of Common Stock held by the James O.
Donnally Revocable Trust over which Mr. Donnally has sole voting and investment power; and (iii) 2,724,105 shares of Common Stock that may be deemed to be beneficially owned by Mr. Donnally, which shares are held by certain trusts,
including (a) 141,659 shares held by the Barbara G. Glockner Trust, for the benefit of Joseph C. Glockner; (b) 141,659 shares held by the Barbara G. Glockner Trust, for the benefit of Michael P. Glockner; (c) 141,659 shares held by the
Barbara G. Glockner Trust, for the benefit of Timothy E. Glockner; (d) 747,834 shares held by the Joseph C. Glockner Revocable Trust; (e) 747,834 shares held by Michael P. Glockner Revocable Trust; (f) 747,834 shares held by the
Timothy E. Glockner Revocable Trust; (g) 3,964 shares held by the Andrew M. Glockner Revocable Trust; and (h) 51,662 shares held by the Barbara G. Glockner Revocable Trust, each of which has three trustees, Timothy Glockner, James
Donnally, and Theresa Laxton, Mr. Donnally’s spouse, with shared voting power. Timothy Glockner has a life estate interest in the Barbara G. Glockner Trust fbo Timothy E. Glockner. The beneficiaries of the Barbara G. Glockner Trust fbo
Timothy E. Glockner are the issue of Timothy Glockner. The beneficiaries of the Barbara G. Glockner Trust fbo Joseph C. Glockner are the issue of Joseph C. Glockner. The beneficiaries of the Barbara G. Glockner Trust fbo Michael P.
Glockner are the issue of Michael P. Glockner.
|
|
(2)
|
Consists of (i) 3,480,607 shares of Common Stock held by Mr. Otworth and (ii) 262,295 shares of Common Stock that Mr. Otworth has
the right to acquire in connection with the vesting of stock options on October 2, 2025.
|
|
(3)
|
Consists of (i) 2,417,719 shares of Common Stock held by Dr. Scott and (ii) 163,934 shares of Common Stock that Dr. Scott has the
right to acquire in connection with the vesting of stock options on October 2, 2025.
|
|
(4)
|
Greg Wasson and Kimberly Wasson share voting and investment power over the securities held by WE-INN LLC. The address for WE-INN
LLC is 233 N Michigan Avenue, Suite 1410, Chicago, Illinois 60601.
|
|
(5)
|
Based on information provided by Ascent Capital Partners LLC in a Schedule 13G filed with the SEC on May 22, 2025. Per such
Schedule 13G, Ascent Capital Partners LLC has sole voting power over all of such shares and sole dispositive power over all of such shares. The principal business address of Ascent Capital Partners LLC is 16427 N Scottsdale Road, Suite
410, Scottsdale, Arizona 85255.
|
|
(6)
|
Mr. Aaron Weitman is the Managing Member of CastleKnight Fund GP, LLC, which is the controlling entity of CastleKnight Master
Fund LP, and accordingly Mr. Weitman may be deemed to have voting and investment power over the shares. The principal business address of CastleKnight Master Fund LP is 888 Seventh Avenue, 24th Floor, New York, New York 10019.
|
|
(7)
|
The 10,198 shares of Series B Preferred Stock held by Christopher and Donna Corley are convertible into 20,396 shares of Common
Stock, assuming the maximum number of shares of Common Stock are issued upon conversion of the Series B Preferred Stock pursuant to its terms, which provide that the conversion price be calculated based on the greater of a fixed amount
and the 10-trading day VWAP of the Common Stock. Mr. Christopher Corley and Mrs. Donna Corley share voting and investment power over the shares.
|
|
(8)
|
The 5,099 shares of Series B Preferred Stock held by Dr. Chi Lim are convertible into 10,198 shares of Common Stock, assuming the
maximum number of shares of Common Stock are issued upon conversion of the Series B Preferred Stock pursuant to its terms, which provide that the conversion price be calculated based on the greater of a fixed amount and the 10-trading
day VWAP of the Common Stock.
|
|
(9)
|
The 50,000 shares of Series C Preferred Stock held by the Crown Global Life Insurance LTD IRO Separate Account 30286 are
convertible into 100,000 shares of Common Stock, assuming the maximum number of shares of Common Stock are issued upon conversion of the Series C Preferred Stock pursuant to its terms, which provide that the conversion price be
calculated based on the greater of a fixed amount and the 10-trading day VWAP of the Common Stock. Ms. Terria Godwin and Ms. Pauline McGettigan are the controlling persons of Crown Global Life Insurance LTD IRO Separate Account 30286
and share voting and investment power equally such that voting and investment decisions require the affirmative agreement of both persons.
|
|
(10)
|
Timothy E. Glockner, Joseph C. Glockner, Michael P. Glockner, and James O. Donnally are members of The Glockner Family Venture
Fund, LP and share equal voting and investment power over the 4,680,272 shares of Common Stock.
|
|
(11)
|
The 10,198 shares of Series B Preferred Stock held by the Javid Mu’az Baksh Living Trust are convertible into 20,396 shares of
Common Stock, assuming the maximum number of shares of Common Stock are issued upon conversion of the Series B Preferred Stock pursuant to its terms, which provide that the conversion price be calculated based on the greater of a fixed
amount and the 10-trading day VWAP of the Common Stock. Mr. Javid Baksh serves as the trustee for the Javid Mu’az Baksh Living Trust and, accordingly, may be deemed to have voting and investment power over the shares.
|
TABLE OF CONTENTS
|
(12)
|
The 7,649 shares of Series B Preferred Stock held by Matthew and Holly Sellers are convertible into 15,298 shares of Common
Stock, assuming the maximum number of shares of Common Stock are issued upon conversion of the Series B Preferred Stock pursuant to its terms, which provide that the conversion price be calculated based on the greater of a fixed amount
and the 10-trading day VWAP of the Common Stock. Mr. Matthew Sellers and Mrs. Holly Sellers share voting and investment power over the shares.
|
|
(13)
|
The 100,000 shares of Series C Preferred Stock held by the Neil Eichelberger 2021 Irrevocable Trust are convertible into
200,000 shares of Common Stock, assuming the maximum number of shares of Common Stock are issued upon conversion of the Series C Preferred Stock pursuant to its terms, which provide that the conversion price be calculated based on the
greater of a fixed amount and the 10-trading day VWAP of the Common Stock. Each of Ms. Leigh Waters and Ms. Marjorie Ann Eichelberger serves as a trustee for the Neil Eichelberger 2021 Irrevocable Trust and has sole voting and
investment power over the shares such that voting and investment decisions do not require the agreement of both persons.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name of Selling Stockholder
|
|
|
Number of
Shares of
Common
Stock
Beneficially
Owned Prior
to Offering
|
|
|
Maximum
Number of
Shares of
Common
Stock to be
Sold Pursuant
to this
Prospectus
|
|
|
Number of
Shares of
Common
Stock
Beneficially
Owned
After
Offering
|
|
|
Percent of
Common
Stock
Beneficially
Owned
After
Offering
|
|
Convertible Debentures and SEPA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
YA II PN, Ltd
|
|
|
3,048,644(1)
|
|
|
21,000,000(2)
|
|
|
—
|
|
|
*
|
|
PIPE Investment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Matthew Briggs
|
|
|
25,000
|
|
|
50,000(3)
|
|
|
—
|
|
|
*
|
|
CastleKnight Master Fund LP
|
|
|
4,286,416
|
|
|
2,400,000(4)
|
|
|
3,086,416
|
|
|
5.32%
|
|
DOMMFT Investments LLC
|
|
|
50,000
|
|
|
100,000(5)
|
|
|
—
|
|
|
*
|
|
Edward P. Hoffman
|
|
|
8,400
|
|
|
16,800(6)
|
|
|
—
|
|
|
*
|
|
Jacob Mermelstein
|
|
|
16,000
|
|
|
32,000(7)
|
|
|
—
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name of Selling Stockholder
|
|
|
Number of
Shares of
Common
Stock
Beneficially
Owned Prior
to Offering
|
|
|
Maximum
Number of
Shares of
Common
Stock to be
Sold Pursuant
to this
Prospectus
|
|
|
Number of
Shares of
Common
Stock
Beneficially
Owned
After
Offering
|
|
|
Percent of
Common
Stock
Beneficially
Owned
After
Offering
|
|
Erick and Wendi Kuebler
|
|
|
8,334
|
|
|
16,668(8)
|
|
|
—
|
|
|
*
|
|
Daivd R. Lipton
|
|
|
4,167
|
|
|
8,334(9)
|
|
|
—
|
|
|
*
|
|
Marvin Mermelstein Descendants’ Trust
|
|
|
50,000
|
|
|
100,000(10)
|
|
|
—
|
|
|
*
|
|
Rappaport Ventures LLC
|
|
|
35,000
|
|
|
70,000(11)
|
|
|
—
|
|
|
*
|
|
Gregory Reyes
|
|
|
216,000
|
|
|
333,334(12)
|
|
|
49,333
|
|
|
*
|
|
David Schneider
|
|
|
9,500
|
|
|
19,000(13)
|
|
|
—
|
|
|
*
|
|
Matthew P. Spain
|
|
|
41,667
|
|
|
83,334(14)
|
|
|
—
|
|
|
*
|
|
YELO Investments II LLC
|
|
|
10,500
|
|
|
21,000(15)
|
|
|
—
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Consists of up to 3,048,644 shares of Common Stock that may be issued to Yorkville pursuant to the SEPA and upon conversion of
the Convertible Debentures issued to Yorkville pursuant to the Purchase Agreements, without exceeding the ownership limitation set forth in the Convertible Debentures. Based on information provided to us, Yorkville acquired the shares
being registered hereunder in the ordinary course of business, and at the time of the acquisition of the shares, Yorkville did not have any agreements or understandings with any person to distribute such shares. The business address of
Yorkville is c/o Mark Angelo, 1012 Springfield Avenue, Mountainside, New Jersey, 07092.
|
|
(2)
|
Consists of (i) up to 12,000,000 shares of Common Stock that may be issued upon conversion of the Convertible Debentures issued
and to be issued to Yorkville pursuant to the Purchase Agreements and (ii) up to 9,000,000 shares of Common Stock that may be issued to Yorkville pursuant to the SEPA.
|
|
(3)
|
Consists of (i) 25,000 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 25,000 shares of Common
Stock that may be issued upon exercise of the Series A Warrants. The business address of the listed Selling Stockholder is 1985 Fagerness Point Road, Wayzata, Minnesota 55391.
|
|
(4)
|
Consists of (i) 1,200,000 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 1,200,000 shares of
Common Stock that may be issued upon exercise of the Series A Warrants. Mr. Aaron Weitman is the Managing Member of CastleKnight Fund GP, LLC, which is the controlling entity of the listed Selling Stockholder, and accordingly
Mr. Weitman may be deemed to have voting and investment power over the shares. The principal business address of the Selling Stockholder is 888 Seventh Avenue, 24th Floor, New York, New York 10019.
|
|
(5)
|
Consists of (i) 50,000 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 50,000 shares of Common
Stock that may be issued upon exercise of the Series A Warrants. Mr. Joel Mermelstein is the ultimate controlling person of the listed Selling Stockholder and, accordingly, may be deemed to have voting and investment power over the
shares. The business address of the listed Selling Stockholder is 6500 N. Hamlin Ave., Lincolnwood, Illinois 60712.
|
|
(6)
|
Consists of (i) 8,400 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 8,400 shares of Common Stock
that may be issued upon exercise of the Series A Warrants. Based on the information provided to us, the Selling Stockholder acquired the shares being registered hereunder as a personal investment, and at the time of the acquisition of
the shares, the Selling Stockholder did not have any agreements or understandings with any person to distribute such shares. The business address of the listed Selling Stockholder is 5950 Sherry Lane, Suite 470, Dallas, Texas 75225.
|
|
(7)
|
Consists of (i) 16,000 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 16,000 shares of Common
Stock that may be issued upon exercise of the Series A Warrants. The business address of the listed Selling Stockholder is 6500 N. Hamlin Ave., Lincolnwood, Illinois 60712.
|
|
(8)
|
Consists of (i) 8,334 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 8,334 shares of Common Stock
that may be issued upon exercise of the Series A Warrants. Mr. Erick Kuebler and Mrs. Wendi Kuebler share voting and investment power over the shares. Based on the information provided to us, the Selling Stockholder acquired the shares
being registered hereunder as a personal investment, and at the time of the acquisition of the shares, the Selling Stockholder did not have any agreements or understandings with any person to distribute such shares. The business address
of the listed Selling Stockholder is 5950 Sherry Lane, Suite 470, Dallas, Texas 75225.
|
|
(9)
|
Consists of (i) 4,167 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 4,167 shares of Common Stock
that may be issued upon exercise of the Series A Warrants. Based on information provided to us, the Selling Stockholder acquired the shares being registered hereunder as a personal investment, and at the time of the acquisition of the
shares, the Selling Stockholder did not have any agreements or understandings with any person to distribute such shares. The business address of the listed Selling Stockholder is 767 3rd Avenue, New York, New York 10017.
|
|
(10)
|
Consists of (i) 50,000 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 50,000 shares of Common
Stock that may be issued upon exercise of the Series A Warrants. Mr. Marvin Mermelstein serves as the trustee for the listed Selling Stockholder and, accordingly, may be deemed to have voting and investment power over the shares. The
business address of the listed Selling Stockholder is 6500 N. Hamlin Ave., Lincolnwood, Illinois 60712.
|
|
(11)
|
Consists of (i) 35,000 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 35,000 shares of Common
Stock that may be issued upon exercise of the Series A Warrants. Mr. Jay Rappaport and Mrs. Corrina Rappaport are the ultimate controlling persons of the listed Selling Stockholder and share voting and investment power over the shares.
The business address of the listed Selling Stockholder is 135 S. Carmelina Ave., Los Angeles, CA 90049.
|
TABLE OF CONTENTS
|
(12)
|
Consists of (i) 166,667 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 166,667 shares of Common
Stock that may be issued upon exercise of the Series A Warrants. The business address of the listed Selling Stockholder is 5510 West Dry Creek Road, Manhattan, Montana 59741.
|
|
(13)
|
Consists of (i) 9,500 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 9,500 shares of Common Stock
that may be issued upon exercise of the Series A Warrants. The business address of the listed Selling Stockholder is 654 Cypress Hills Drive, Encinitas, California 92024.
|
|
(14)
|
Consists of (i) 41,667 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 41,667 shares of Common
Stock that may be issued upon exercise of the Series A Warrants. The business address of the listed Selling Stockholder is 647 Shore Drive, Boynton Beach, Florida 33435.
|
|
(15)
|
Consists of (i) 10,500 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 10,500 shares of Common
Stock that may be issued upon exercise of the Series A Warrants. Mr. Joel Mermelstein is the ultimate controlling person of the listed Selling Stockholder and, accordingly, may be deemed to have voting and investment power over the
shares. The business address of the listed Selling Stockholder is 6500 N. Hamlin Ave., Lincolnwood, Illinois 60712.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
one percent (1%) of the total number of Common Stock then outstanding; or
|
|
•
|
the average weekly reported trading volume of Common Stock during the four calendar weeks preceding the filing of a notice on
Form 144 with respect to the sale.
|
|
•
|
the issuer of the securities that was formerly a shell company has ceased to be a shell company;
|
|
•
|
the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;
|
|
•
|
the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the
preceding twelve months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and
|
|
•
|
at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its
status as an entity that is not a shell company.
|
TABLE OF CONTENTS
|
•
|
ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
|
|
•
|
block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of
the block as principal to facilitate the transaction;
|
|
•
|
purchases by a broker-dealer as principal and resale by the broker-dealer for its account;
|
|
•
|
an exchange distribution in accordance with the rules of the applicable exchange;
|
|
•
|
privately negotiated transactions;
|
|
•
|
in underwritten transactions;
|
|
•
|
settlement of short sales;
|
|
•
|
in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at
a stipulated price per security;
|
|
•
|
through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
|
|
•
|
distribution to members, limited partners or stockholders of Selling Stockholders;
|
|
•
|
“at the market” or through market makers or into an existing market for the shares;
|
|
•
|
a combination of any such methods of sale; or
|
|
•
|
any other method permitted pursuant to applicable law.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
Audited Consolidated Financial Statements
|
|
|
|
|
Report of Independent Registered Public Accounting Firm
(BDO USA, P.C.; PCAOB ID# 243)
|
|
|
F-2
|
|
Consolidated Balance Sheets as of December 31, 2024 and
2023
|
|
|
F-3
|
|
Consolidated Statements of
Operations and Comprehensive Income (Loss) for the period October 2, 2024 through December 31, 2024 (Successor), January 1, 2024 through October 1, 2024 (Predecessor) and the year ended December 31, 2023 (Predecessor)
|
|
|
F-5
|
|
Consolidated Statement of Changes
in Mezzanine Capital for the period January 1, 2024 through October 1, 2024 (Predecessor) and the year ended December 31, 2023 (Predecessor)
|
|
|
F-6
|
|
Consolidated Statement of Changes in
Stockholders’ Equity for the period October 2, 2024 through December 31, 2024 (Successor), January 1, 2024 through October 1, 2024 (Predecessor) and the year ended December 31, 2023 (Predecessor)
|
|
|
F-8
|
|
Consolidated Statements of Cash
Flows for the period October 2, 2024 through December 31, 2024 (Successor), January 1, 2024 through October 1, 2024 (Predecessor) and the year ended December 31, 2023 (Predecessor)
|
|
|
F-9
|
|
Notes to Consolidated Financial Statements
|
|
|
F-11-F-51
|
|
|
|
|
|
|
|
|
|
|
|
Unaudited Consolidated Financial Statements
|
|
|
|
|
Condensed Consolidated Balance Sheets as of June 30, 2025
(Unaudited) and December 31, 2024
|
|
|
F-52
|
|
Unaudited Condensed Consolidated
Statements of Operations and Comprehensive Income (Loss) for the Three and Six Months ended June 30, 2025 (Successor) and June 30, 2024 (Predecessor)
|
|
|
F-53
|
|
Unaudited Condensed Consolidated
Statements of Changes in Unitholders’ Deficit (Predecessor) for the Three and Six Months ended June 30, 2024
|
|
|
F-54
|
|
Unaudited Condensed Consolidated
Statements of Changes in Mezzanine and Stockholders’ Equity (Deficit) (Successor) for the Three and Six Months ended June 30, 2025
|
|
|
F-55
|
|
Unaudited Condensed Consolidated
Statements of Cash Flows for the Six Months ended June 30, 2025 (Successor) and June 30, 2024 (Predecessor)
|
|
|
F-56
|
|
Notes to Condensed Consolidated Financial Statements
(Unaudited)
|
|
|
F-58-F-80
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
|
December 31, 2024
|
|
|
December 31, 2023
|
|
Assets
|
|
|
|
|
|
|
|
Cash, cash equivalents and restricted cash
|
|
|
$
|
|
|
$
|
|
Accounts receivable
|
|
|
|
|
|
|
|
Due from related parties
|
|
|
|
|
|
|
|
Inventories
|
|
|
|
|
|
|
|
Prepaid expenses and other current assets
|
|
|
|
|
|
|
|
Total Current Assets
|
|
|
|
|
|
|
|
Investments
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
|
|
|
|
|
Intangible assets, net
|
|
|
|
|
|
|
|
Goodwill
|
|
|
|
|
|
|
|
Other assets
|
|
|
|
|
|
|
|
Total Assets
|
|
|
$
|
|
|
$
|
|
Liabilities and Stockholders’ Deficit
|
|
|
|
|
|
|
|
Accounts payable
|
|
|
$
|
|
|
$$
|
|
Accrued employee benefits
|
|
|
|
|
|
|
|
Accrued expenses
|
|
|
|
|
|
|
|
Related party payables
|
|
|
|
|
|
|
|
Related party notes payable - current
|
|
|
|
|
|
|
|
Notes payable - current
|
|
|
|
|
|
|
|
Patent installment payable - current
|
|
|
|
|
|
|
|
Obligation to issue equity
|
|
|
|
|
|
|
|
Warrant liability
|
|
|
|
|
|
|
|
Other current liabilities
|
|
|
|
|
|
|
|
Total Current Liabilities
|
|
|
|
|
|
|
|
Notes payable, net of current portion
|
|
|
|
|
|
|
|
Convertible promissory note, net
|
|
|
|
|
|
|
|
Convertible promissory note due to related party, net
|
|
|
|
|
|
|
|
Embedded derivative liability
|
|
|
|
|
|
|
|
Earnout liability
|
|
|
|
|
|
|
|
Stock-based compensation liability
|
|
|
|
|
|
|
|
Patent installment payable, net of current
|
|
|
|
|
|
|
|
Deferred income taxes
|
|
|
|
|
|
|
|
Other liabilities
|
|
|
|
|
|
|
|
Total Liabilities
|
|
|
|
|
|
|
|
Commitments and Contingencies (Note 19)
|
|
|
|
|
|
|
|
Mezzanine Capital
|
|
|
|
|
|
|
|
Redeemable Class I Units, no par value,
|
|
|
|
|
|
|
|
Redeemable Class PCTA Units, no par value,
|
|
|
|
|
|
|
|
Stockholders’ Equity / Unitholders’ Deficit
|
|
|
|
|
|
|
|
Class B Preferred Units, no par value,
|
|
|
—
|
|
|
|
|
Class B-1 Preferred Units, no par value,
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
|
December 31, 2024
|
|
|
December 31, 2023
|
|
Class A Units, no par value,
|
|
|
—
|
|
|
|
|
Class C Units, no par value,
|
|
|
—
|
|
|
|
|
Preferred Stock, $
|
|
|
|
|
|
—
|
|
Common Stock, $
|
|
|
|
|
|
—
|
|
Additional paid-in capital
|
|
|
|
|
|
|
|
Accumulated other comprehensive gain (loss)
|
|
|
|
|
|
|
|
Accumulated deficit
|
|
|
(
|
|
|
(
|
|
Total Innventure, Inc.,
Stockholders’ Equity/ Innventure LLC Unitholders’ Deficit
|
|
|
|
|
|
(
|
|
Non-controlling interest
|
|
|
|
|
|
|
|
Total Stockholders’ Equity/ Unitholders’ Deficit
|
|
|
|
|
|
(
|
|
Total Liabilities, Mezzanine Capital and Equity
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Revenue
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Expenses
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
|
|
|
|
|
|
|
|
General and administrative
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
|
|
|
|
|
|
|
|
Total Operating Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from Operations
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-operating (Expense) and Income
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Net gain (loss) from investments
|
|
|
|
|
|
|
|
|
(
|
|
Net (loss) gain on investments - due to related parties
|
|
|
|
|
|
(
|
|
|
|
|
Change in fair value of financial liabilities
|
|
|
(
|
|
|
(
|
|
|
|
|
Equity method investment (loss) income
|
|
|
(
|
|
|
|
|
|
(
|
|
Loss on conversion of promissory notes
|
|
|
|
|
|
(
|
|
|
|
|
Write-off of loan commitment fee asset
|
|
|
(
|
|
|
|
|
|
|
|
Miscellaneous other expense
|
|
|
(
|
|
|
(
|
|
|
|
|
Total Non-operating (Expense) Income
|
|
|
(
|
|
|
|
|
|
(
|
|
Loss before Income Taxes
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Income tax expense (benefit)
|
|
|
(
|
|
|
|
|
|
|
|
Net Loss
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Less: net loss attributable to Non-redeemable
non-controlling interest
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Net Loss Attributable to
Innventure, Inc. Stockholders / Innventure LLC Unitholders
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted loss per share
|
|
|
$(
|
|
|
|
|
|
|
|
Basic and diluted weighted average common shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income, net of taxes:
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain on available-for-sale debt
securities - related party
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive loss, net of taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive loss, net of taxes
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Less: comprehensive income attributable to
Non-redeemable non-controlling interest
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Net Comprehensive Loss
Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class I
Amount
|
|
|
Class PCTA
Amount
|
|
|
Total
|
|
December 31, 2022
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Proceeds from capital calls to unitholders
|
|
|
|
|
|
|
|
|
|
|
Accretion of redeemable units to redemption value
|
|
|
(
|
|
|
(
|
|
|
(
|
|
December 31, 2023
|
|
|
|
|
|
|
|
|
|
|
Accretion of redeemable units to redemption value
|
|
|
|
|
|
|
|
|
|
|
October 1, 2024
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class B
Preferred
|
|
|
Class B-1
Preferred
|
|
|
Class A
|
|
|
Class C
|
|
|
Accumulated
Deficit
|
|
|
Accumulated
OCI
|
|
|
Non-
Controlling
Interest
|
|
|
Total
Unitholders’
Deficit
|
|
December 31, 2022 (Predecessor)
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
Net loss
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
(
|
|
|
(
|
|
Non-controlling interest acquired
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Issuance of units, net of issuance costs
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
Unit-based compensation
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Distributions to unitholders
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
—
|
|
|
(
|
|
Accretion of redeemable units to redemption value
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
December 31, 2023 (Predecessor)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
|
|
|
|
(
|
|
Net loss
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
(
|
|
|
(
|
|
Other comprehensive loss, net of taxes
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
Units issued to non-controlling interest
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Issuance of units, net of issuance costs
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,561
|
|
Unit-based compensation
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Issuance of units to non-controlling interest in
exchange of convertible promissory notes
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Accretion of redeemable units to redemption value
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
—
|
|
|
(
|
|
October 1, 2024 (Predecessor)
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
Series B
Preferred Stock
|
|
|
Common Stock
|
|
|
Additional
Paid-In
Capital
|
|
|
Accumulated
Deficit
|
|
|
Accumulated
OCI
|
|
|
Non-
Controlling
Interest
|
|
|
Total
Stockholders’
Equity
|
||||||
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
||||||||||||||
|
October 2, 2024 (Successor)
|
|
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
Effect of acquisition of Innventure LLC
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Reclassification of warrants from liability to
equity
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
Issuance of common shares, net of issuance costs
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
Issuance of preferred shares, net of issuance costs
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
Issuance of common shares from warrant exercises
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
Net loss
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
(
|
|
|
(
|
|
Other comprehensive gain, net of taxes
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
Non-controlling interest acquired
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Distributions to Stockholders
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
—
|
|
|
(
|
|
Vesting of contingent at risk sponsor shares
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Stock-based compensation
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Accrued preferred dividends
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
December 31, 2024 (Successor)
|
|
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Cash Flows Used in Operating Activities
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
Adjustments to reconcile net
loss to net cash and cash equivalents used in operating activities:
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
Interest income on debt securities - related party
|
|
|
(
|
|
|
(
|
|
|
|
|
Change in fair value of financial liabilities
|
|
|
|
|
|
|
|
|
(
|
|
Change in fair value of payables due to related parties
|
|
|
|
|
|
|
|
|
(
|
|
Write-off of loan commitment fee asset
|
|
|
|
|
|
|
|
|
|
|
Non-cash interest expense on notes payable
|
|
|
|
|
|
|
|
|
|
|
Net (gain) loss on investments
|
|
|
|
|
|
(
|
|
|
|
|
Equity method investment gain (loss)
|
|
|
|
|
|
(
|
|
|
|
|
Loss on conversion of promissory notes
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes
|
|
|
(
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
|
|
|
|
|
|
|
Payment of patent installment
|
|
|
|
|
|
(
|
|
|
|
|
Non-cash rent costs
|
|
|
|
|
|
|
|
|
|
|
Accrued unpaid interest on note payable
|
|
|
|
|
|
|
|
|
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(
|
|
|
(
|
|
|
|
|
Prepaid expenses and other current assets
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Inventory
|
|
|
(
|
|
|
(
|
|
|
|
|
Accounts payable
|
|
|
(
|
|
|
|
|
|
|
|
Accrued employee benefits
|
|
|
|
|
|
|
|
|
|
|
Accrued expenses
|
|
|
(
|
|
|
|
|
|
|
|
Stock-based compensation liability
|
|
|
|
|
|
|
|
|
|
|
Other current liabilities
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Obligation to issue equity
|
|
|
|
|
|
|
|
|
|
|
Other assets
|
|
|
|
|
|
(
|
|
|
(
|
|
Net Cash Used in Operating Activities
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows Provided by (Used in) Investing Activities
|
|
|
|
|
|
|
|
|
|
|
Purchase of shares in equity method investee
|
|
|
|
|
|
|
|
|
(
|
|
Contributions to equity method investee
|
|
|
|
|
|
|
|
|
(
|
|
Investment in debt securities - equity method investee
|
|
|
|
|
|
(
|
|
|
(
|
|
Advances to equity method investee
|
|
|
(
|
|
|
(
|
|
|
|
|
Acquisition of property, plant and equipment
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Acquisition of intangible assets
|
|
|
(
|
|
|
|
|
|
|
|
Acquisition of net assets, net of cash acquired,
through business combination
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of investments
|
|
|
|
|
|
|
|
|
|
|
Cash withdrawn from trust as a result of business
combination
|
|
|
|
|
|
|
|
|
|
|
Net Cash Provided by (Used in) Investing Activities
|
|
|
|
|
|
(
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows Provided by Financing Activities
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of equity, net of issuance costs
|
|
|
|
|
|
|
|
|
|
|
Proceeds from the issuance of equity to
non-controlling interest, net of issuance costs
|
|
|
|
|
|
|
|
|
|
|
Proceeds from the issuance of convertible promissory
note
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of debt securities, net of
issuance costs
|
|
|
|
|
|
|
|
|
|
|
Payment of debts
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Receipt of Capital from Class I Unitholder
|
|
|
|
|
|
|
|
|
|
|
Distributions to Stockholders
|
|
|
(
|
|
|
|
|
|
(
|
|
Proceeds from the issuance of promissory notes to
related parties
|
|
|
|
|
|
|
|
|
|
|
Repayment of promissory note
|
|
|
(
|
|
|
|
|
|
|
|
Cash Flows Provided by Financing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Increase (Decrease) in Cash, Cash Equivalents
and Restricted Cash
|
|
|
|
|
|
|
|
|
(
|
|
Cash, Cash Equivalents and Restricted Cash Beginning
of period
|
|
|
|
|
|
|
|
|
|
|
Cash, Cash Equivalents and Restricted Cash End of
period
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Supplemental Cash Flow Information
|
|
|
|
|
|
|
|
|
|
|
Cash paid for interest
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Supplemental Disclosure of
Noncash Financing Information
|
|
|
|
|
|
|
|
|
|
|
Accretion of redeemable units to redemption value
|
|
|
|
|
|
|
|
|
|
|
Debt discount and embedded derivative upon issuance
|
|
|
|
|
|
|
|
|
|
|
Issuance of units to non-controlling interest in
exchange of convertible promissory notes
|
|
|
|
|
|
|
|
|
|
|
Conversion of working capital loans to equity method
investees into investments in debt securities - related party
|
|
|
|
|
|
|
|
|
|
|
Transfer of liability warrants to equity warrants in
the Business Combination
|
|
|
|
|
|
|
|
|
|
|
Initial recognition of loan commitment fee
|
|
|
|
|
|
|
|
|
|
|
Transfer of loan commitment fee asset
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
|
December 31, 2024
|
|
|
December 31, 2023
|
|
Equity-method investments
|
|
|
$
|
|
|
$
|
|
Exchange-traded investments at fair value
|
|
|
|
|
|
|
|
Investment in debt securities - AFS
|
|
|
|
|
|
|
|
Total Investments
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||||||
|
|
|
|
Successor
|
|
|
Predecessor
|
||||||
|
|
|
|
December 31, 2024
|
|
|
December 31, 2023
|
||||||
|
Asset type
|
|
|
Carrying
Amount
|
|
|
Maximum Exposure
to Loss
|
|
|
Carrying
Amount
|
|
|
Maximum Exposure
to Loss
|
|
Equity method investment in AeroFlexx
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Investments in debt securities - AFS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Due from related party
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
ESG Fund
|
|
|
AeroFlexx
|
||||||
|
|
|
|
December 31,
|
|
|
December 31,
|
||||||
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Total Assets
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Total Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Equity (Deficit)
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||||||
|
|
|
|
ESG Fund
|
|
|
AeroFlexx
|
||||||
|
|
|
|
Years ended
December 31,
|
|
|
Years ended
December 31,
|
||||||
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Revenue
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Gross (Loss) Profit
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
|
|
Net Income (Loss)
|
|
|
$
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortized cost
|
|
|
Gross unrealized
gains
|
|
|
Fair value
|
|
Investment in Debt Securities - AFS
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
Amortized cost
|
|
|
Fair value
|
|
Due within one year
|
|
|
$
|
|
|
$
|
|
Due after one year through five years
|
|
|
|
|
|
|
|
Due after five years
|
|
|
|
|
|
|
|
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2024 (Successor)
|
|
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
|
Significant Other
Observable Inputs
(Level 2)
|
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
|
Total
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in debt security - AFS
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnout liability
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
WTI warrant liability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private placement warrant liability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2023 (Predecessor)
|
|
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
|
Significant Other
Observable Inputs
(Level 2)
|
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
|
Total
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-traded investments at FVTNI
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Embedded derivative liability
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Related party payables
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward
Contract
|
|
|
Embedded
Derivative
Liability
|
|
|
Investment
in debt
securities - AFS
|
|
|
Earnout
Liability
|
|
|
WTI Warrant
Liability
|
|
Balance as of January 1, 2023 (Predecessor)
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Additions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value
|
|
|
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2023 (Predecessor)
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Additions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Settlement
|
|
|
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
Change in fair value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of October 1, 2024 (Predecessor)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of October 2, 2024 (Successor)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Settlement
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2024 (Successor)
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
Embedded derivative within 2025
Note issued August 18, 2022
with a principal balance of $
|
|
|
Settlement
|
|
|
December 31, 2023
|
|
Discount Rate
|
|
|
|
|
|
|
|
Probability of Expected Outcomes
|
|
|
|
|
|
|
|
Financing
|
|
|
|
|
|
|
|
Change in control
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Embedded derivative within 2025
Notes issued June 7 & July 3, 2023
with an aggregate principal balance
of $
|
|
|
|
|
|
|
|
Discount Rate
|
|
|
|
|
|
|
|
Probability of Expected Outcomes
|
|
|
|
|
|
|
|
Financing
|
|
|
|
|
|
|
|
Change in control
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 2, 2024
|
|
|
December 31, 2024
|
|
Volatility
|
|
|
|
|
|
|
|
Time to liquidity
|
|
|
|
|
|
|
|
Discount for lack of marketability
|
|
|
|
|
|
|
|
Weighted average cost of capital
|
|
|
|
|
|
|
|
Risk-free rate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
October 2,
2024
|
|
|
December 31,
2024
|
|
Term
|
|
|
|
|
|
|
|
Stock price
|
|
|
$
|
|
|
$
|
|
Volatility
|
|
|
|
|
|
|
|
Risk-Free Rate
|
|
|
|
|
|
|
|
Dividend Yield
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 2,
2024
|
|
Revenue risk premium
|
|
|
|
|
Revenue volatility
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 2,
2024
|
|
|
December 31,
2024
|
|
Revenue risk premium
|
|
|
|
|
|
|
|
Revenue volatility
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
October 22,
2024
|
|
|
December 31,
2024
|
|
Stock Price
|
|
|
$
|
|
|
$
|
|
Stock Price Volatility
|
|
|
|
|
|
|
|
Credit Spread
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
Successor
|
|
|
Predecessor
|
||||||
|
|
|
|
Maturities
|
|
|
December 31, 2024
|
|
|
Interest Rates
|
|
|
December 31, 2023
|
|
|
Interest Rates
|
|
Series 1 promissory notes
|
|
|
2025 - 2026
|
|
|
$
|
|
|
|
|
|
$
|
|
|
|
|
Related party notes
|
|
|
2024 - 2025
|
|
|
|
|
|
|
|
|
|
|
|
—%
|
|
Convertible promissory notes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WTI Facility
|
|
|
2028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Notes Payable
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: unamortized debt discount
|
|
|
|
|
|
(
|
|
|
|
|
|
(
|
|
|
|
|
Less: current portion of related party notes payable
|
|
|
|
|
|
(
|
|
|
|
|
|
(
|
|
|
|
|
Less: current portion of notes payable
|
|
|
|
|
|
(
|
|
|
|
|
|
(
|
|
|
|
|
Total Long-term Notes
|
|
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ending December 31,
|
|
|
Amount
|
|
2025
|
|
|
$
|
|
2026
|
|
|
|
|
2027
|
|
|
|
|
2028
|
|
|
|
|
Total Debt
|
|
|
$
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Principal amount
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Number of shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
|
Interest Rate
|
|
|
December 31, 2024
|
|
|
December 31, 2023
|
|
Principal amount of 1st extension promissory notes
|
|
|
|
|
|
$
|
|
|
$
|
|
Principal amount of 2nd extension promissory notes
|
|
|
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Interest attributable to contractual interest
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Interest attributable to amortization of issuance costs
|
|
|
|
|
|
|
|
|
|
|
Total interest expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Total interest expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Interest attributable to contractual interest
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Interest attributable to amortization of implied discounts
|
|
|
|
|
|
|
|
|
|
|
Total interest expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Interest attributable to contractual interest
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Interest attributable to amortization of issuance costs
|
|
|
|
|
|
|
|
|
|
|
Total interest expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
|
December 31, 2024
|
|
|
December 31, 2023
|
|
Raw materials
|
|
|
$
|
|
|
$
|
|
Work in process
|
|
|
|
|
|
|
|
Finished goods
|
|
|
|
|
|
|
|
Total inventories
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
|
December 31, 2024
|
|
|
December 31, 2023
|
|
Leasehold improvements
|
|
|
$
|
|
|
$
|
|
Machinery & equipment
|
|
|
|
|
|
|
|
Computers & office equipment
|
|
|
|
|
|
|
|
Construction in progress
|
|
|
|
|
|
|
|
Property, Plant and Equipment, Gross
|
|
|
|
|
|
|
|
Less: Accumulated depreciation
|
|
|
(
|
|
|
(
|
|
Property, Plant and Equipment, Net
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
Period from
October 2, 2024
through
December 31, 2024
|
|
|
Period from
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Depreciation Expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
Innventure LLC Units
|
|
|
Immediately
Prior to Closing
|
|
|
Common Stock
Conversion Ratio
|
|
|
Common Stock
Upon Closing
|
|
Class B Preferred Units
|
|
|
|
|
|
|
|
|
|
|
Class B-1 Preferred Units
|
|
|
|
|
|
|
|
|
|
|
Class A Units
|
|
|
|
|
|
|
|
|
|
|
Class C Units
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Learn CW Shares
|
|
|
|
|
|
|
|
|
|
|
Learn CW Public shareholders
|
|
|
|
|
|
|
|
|
|
|
Learn CW Class B Shareholders
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Learn CW shares subject to clawback provisions
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Common Stock Issued and Outstanding at Closing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Holdco Common Stock transferred to Innventure Members(1)
|
|
|
$
|
|
Contingent consideration(2)
|
|
|
|
|
Consideration transferred
|
|
|
|
|
Non-controlling interest(3)
|
|
|
|
|
Total business enterprise value
|
|
|
$
|
|
|
|
|
|
TABLE OF CONTENTS
|
(1)
|
Represents the fair value of the
|
|
(2)
|
Represents the fair value of the Company Earnout Shares issued and contingently issuable to Innventure Members. Refer to Note 10.
Earnout Shares for more details.
|
|
(3)
|
The non-controlling interest represents the fair value of equity in Accelsius held by non-controlling parties. The fair value is
calculated using a discounted cash flow methodology to determine the Accelsius equity value which is pro rated by the non-controlling ownership percentage (Level 3). Significant inputs used to measure the fair value of the
non-controlling interest include the long-term growth rate of
|
|
|
|
|
|
|
|
|
|
Amount
|
|
Cash consideration transferred
|
|
|
$
|
|
Add: Cash and cash equivalents acquired
|
|
|
|
|
Investing cash flow activity as a result of the
Business Combination
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount
|
|
Cash proceeds from Learn CW trust account
|
|
|
$
|
|
Net cash proceeds from Series B Preferred Stock issuance
|
|
|
|
|
Total Innventure, Inc. cash sources
|
|
|
$
|
|
|
|
|
|
|
Payment of Learn CW accounts payable and accrued expenses
|
|
|
$
|
|
Payment of Learn CW promissory note due to Sponsor
|
|
|
|
|
Payment of Innventure LLC transaction costs at Closing
|
|
|
|
|
Total cash uses
|
|
|
$
|
|
Net cash proceeds
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount
|
|
Assets acquired:
|
|
|
|
|
Cash and cash equivalents
|
|
|
$
|
|
Accounts receivable
|
|
|
|
|
Due from related parties
|
|
|
|
|
Inventory
|
|
|
|
|
Prepaid expenses and other current assets
|
|
|
|
|
Equity method investments
|
|
|
|
|
Investment in debt securities - AFS
|
|
|
|
|
Property, plant, and equipment
|
|
|
|
|
Intangible assets
|
|
|
|
|
Other assets
|
|
|
|
|
Total assets acquired:
|
|
|
$
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
Amount
|
|
Liabilities assumed:
|
|
|
|
|
Accounts payable
|
|
|
$
|
|
Accrued employee benefits
|
|
|
|
|
Accrued expenses
|
|
|
|
|
Related party payable
|
|
|
|
|
Notes payable
|
|
|
|
|
Patent installment payable
|
|
|
|
|
Deferred tax liability
|
|
|
|
|
Other liabilities
|
|
|
|
|
Total liabilities assumed:
|
|
|
$
|
|
Net identifiable assets acquired
|
|
|
$
|
|
Goodwill
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount
|
|
Trade names
|
|
|
|
|
Customer relationships
|
|
|
|
|
Developed technology
|
|
|
|
|
Total
|
|
|
$
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
December 31, 2024 (Successor)
|
||||||
|
Intangible Asset
|
|
|
Weighted-Average
Amortization
Period (years)
|
|
|
Gross Carrying
Amount
|
|
|
Accumulated
Amortization
|
|
|
Net Carrying
Amount
|
|
Trade names
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
Customer relationships
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
Developed technology
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
Other finite-lived intangible assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total intangible assets
|
|
|
|
|
|
$
|
|
|
$(
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization
Expense
|
|
2025
|
|
|
$
|
|
2026
|
|
|
|
|
2027
|
|
|
|
|
2028
|
|
|
|
|
2029
|
|
|
|
|
Thereafter
|
|
|
|
|
Total
|
|
|
$
|
|
|
|
|
|
TABLE OF CONTENTS
|
•
|
|
|
•
|
|
|
•
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Public
Warrants
|
|
|
Number of Private
Warrants
|
|
|
Number of WTI
Warrants
|
|
Outstanding, October 2, 2024 (Successor)
|
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(
|
|
|
|
|
|
|
|
Issued
|
|
|
|
|
|
|
|
|
|
|
Outstanding, December 31, 2024 (Successor)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
|
|
Number of
Warrants
|
|
|
Exercise
Price
|
|
|
Expiration
Date
|
|
|
December 31, 2024
Balance
|
|
Private Warrants
|
|
|
|
|
|
$
|
|
|
10/2/2029
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
•
|
If the WTI Lenders choose to exercise the warrants for Common Stock, the exercise price is $
|
|
•
|
If the WTI Lenders choose to exercise the warrants for Subsequent Round Stock, the exercise price shall be the lowest price per
share paid by any person for the Company’s equity securities issued in a corresponding subsequent round.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
|
|
Number of
Warrants
|
|
|
Exercise
Price
|
|
|
Expiration
Date
|
|
|
December 31, 2024
Balance
|
|
WTI Warrants
|
|
|
|
|
|
varies
|
|
|
3/31/2025
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
Period from
October 2, 2024
through
December 31, 2024
|
|
|
Period from
January 1 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Compensation expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares
|
|
|
Weighted Average
Grant Date
air Value
(per share)
|
|
Granted on December 9, 2024
|
|
|
|
|
|
$
|
|
Vested
|
|
|
|
|
|
|
|
Forfeited
|
|
|
|
|
|
|
|
Non-vested at December 31, 2024
|
|
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares
|
|
|
Weighted
Average
Exercise Price
|
|
|
Weighted Average
Grant Date
Fair Value
(per share)
|
|
Granted on December 9, 2024
|
|
|
|
|
|
$
|
|
|
$
|
|
Vested
|
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2024
|
|
|
|
|
|
$
|
|
|
$
|
|
Exercisable at December 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
Cash-settled SARs
|
|
|
Stock-settled SARs
|
||||||||||||
|
|
|
|
Number of
Shares
|
|
|
Weighted
Average
Exercise
Price
|
|
|
Weighted
Average
Grant Date
Fair Value
(per share)
|
|
|
Number of
Shares
|
|
|
Weighted
Average
Exercise
Price
|
|
|
Weighted
Average
Grant Date
Fair Value
(per share)
|
|
Granted on December 9, 2024
|
|
|
|
|
|
$
|
|
|
$
|
|
|
|
|
|
$
|
|
|
$
|
|
Vested
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2024
|
|
|
|
|
|
$
|
|
|
$
|
|
|
|
|
|
$
|
|
|
$
|
|
Exercisable at December 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor Period
|
|
|
Predecessor Period
|
|||
|
|
|
|
Period from
October 2, 2024
through
December 31, 2024
|
|
|
Period from
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Compensation expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Class C units granted
|
|
|
|
|
|
|
|
|
|
|
Weighted average grant date fair value per share
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Product revenue
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Management fees - related party
|
|
|
|
|
|
|
|
|
|
|
Consulting revenue
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Customer A - Related Party
|
|
|
|
|
|
|
|
|
|
|
Customer B - Related Party
|
|
|
|
|
|
|
|
|
|
|
Customer C
|
|
|
|
|
|
|
|
|
|
|
Customer D
|
|
|
|
|
|
|
|
|
|
|
Customer E
|
|
|
|
|
|
|
|
|
|
|
Total Revenue Concentration of Major Customers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Current Expense:
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
|
|
|
|
|
|
|
|
State
|
|
|
|
|
|
|
|
|
|
|
Foreign
|
|
|
|
|
|
|
|
|
|
|
Total Current Expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred Expense:
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
(
|
|
|
|
|
|
|
|
State
|
|
|
|
|
|
|
|
|
|
|
Foreign
|
|
|
|
|
|
|
|
|
|
|
Total Deferred Expense
|
|
|
(
|
|
|
|
|
|
|
|
Total Expense:
|
|
|
$(
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Pre-tax book loss
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
Income taxes at federal statutory rate
|
|
|
(
|
|
|
|
|
|
|
|
State taxes, net of federal benefit
|
|
|
(
|
|
|
|
|
|
|
|
Tax on pre-tax earnings of corporate subsidiaries
|
|
|
|
|
|
(
|
|
|
(
|
|
Warrant liability
|
|
|
|
|
|
|
|
|
|
|
Non-deductible expenses
|
|
|
|
|
|
|
|
|
|
|
Change in earnout fair value
|
|
|
(
|
|
|
|
|
|
|
|
Other permanent differences
|
|
|
(
|
|
|
|
|
|
(
|
|
Change in valuation allowance
|
|
|
|
|
|
|
|
|
|
|
R&D credit
|
|
|
(
|
|
|
|
|
|
|
|
Total provision (benefit) for income taxes
|
|
|
$(
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
2024
|
|
|
December 31,
2023
|
|
Deferred Tax Assets:
|
|
|
|
|
|
|
|
Deferred lease liabilities
|
|
|
$
|
|
|
$
|
|
Capitalized R&D expense
|
|
|
|
|
|
|
|
Fixed assets and intangibles
|
|
|
|
|
|
|
|
Reserves and other accruals
|
|
|
|
|
|
|
|
Loss carry-forwards and other tax attributes
|
|
|
|
|
|
|
|
Total Deferred Tax Assets
|
|
|
|
|
|
|
|
Less: Valuation allowance
|
|
|
(
|
|
|
(
|
|
Net Deferred Tax Assets
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
Deferred Tax Liabilities:
|
|
|
|
|
|
|
|
Amortization
|
|
|
$(
|
|
|
$(
|
|
Investment in Partnerships
|
|
|
(
|
|
|
|
|
Right of use assets
|
|
|
(
|
|
|
(
|
|
Total Deferred Tax Liabilities
|
|
|
(
|
|
|
(
|
|
Net Deferred Tax Liabilities
|
|
|
$(
|
|
|
$
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
Successor
|
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
Numerator:
|
|
|
|
|
Net loss attributable to Innventure, Inc. shareholders
|
|
|
$(
|
|
Less: Cumulative earnings to participating securities
|
|
|
|
|
Undistributed loss for participating securities
|
|
|
(
|
|
Less: Undistributed loss attributable to participating securities
|
|
|
|
|
Net Loss attributable to common shareholders, basic
and diluted
|
|
|
$(
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
Successor
|
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
Denominator:
|
|
|
|
|
Weighted average number of units outstanding, basic and diluted
|
|
|
|
|
Net loss per share attributable to common
shareholders, basic and diluted
|
|
|
$(
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
|
|
December 31, 2024
|
|
Public warrants
|
|
|
|
|
Private placement warrants
|
|
|
|
|
WTI warrants
|
|
|
|
|
Series B preferred shares
|
|
|
|
|
Share options
|
|
|
|
|
RSUs
|
|
|
|
|
SARs
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
Years Ending December 31,
|
|
|
Amount
|
|
2025
|
|
|
$
|
|
2026
|
|
|
|
|
2027
|
|
|
|
|
2028
|
|
|
|
|
2029
|
|
|
|
|
Thereafter
|
|
|
|
|
Total
|
|
|
$
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Revenue from external customers
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Interest income
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Employee costs
|
|
|
|
|
|
|
|
|
|
|
Facilities, equipment & supplies
|
|
|
|
|
|
|
|
|
|
|
General and administrative
|
|
|
|
|
|
|
|
|
|
|
Outside services
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
|
|
|
|
|
|
|
|
Depreciation expense*
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
|
|
|
|
|
|
|
|
Income tax expense (benefit)
|
|
|
(
|
|
|
|
|
|
|
|
Other**
|
|
|
|
|
|
|
|
|
(
|
|
Total Expenses
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Net Loss
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
Represents depreciation not already included in Cost of sales.
|
|
**
|
Other - change in fair value of financial liabilities, loss on conversion of promissory notes, travel and other miscellaneous
expenses.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||
|
|
|
|
Successor
|
|
|
Predecessor
|
|||
|
|
|
|
October 2, 2024
through
December 31, 2024
|
|
|
January 1, 2024
through
October 1, 2024
|
|
|
Year ended
December 31, 2023
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
Elimination of management services provided to
Technology
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Consolidated Revenues
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Expense:
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
Consolidated Interest Expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Income:
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
Consolidated Interest Income
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and Amortization Expense:
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
Consolidated Depreciation and Amortization Expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss:
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
Other
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Consolidated Net Loss
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Expenditures:
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
Consolidated Capital Expenditures
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2025
(Unaudited)
|
|
|
December 31, 2024
|
|
Assets
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
$
|
|
|
$
|
|
Accounts receivable, net
|
|
|
|
|
|
|
|
Due from related parties
|
|
|
|
|
|
|
|
Inventories, net
|
|
|
|
|
|
|
|
Prepaid expenses and other current assets
|
|
|
|
|
|
|
|
Total Current Assets
|
|
|
|
|
|
|
|
Restricted cash
|
|
|
|
|
|
|
|
Investments
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
|
|
|
|
|
Intangible assets, net
|
|
|
|
|
|
|
|
Goodwill
|
|
|
|
|
|
|
|
Other assets
|
|
|
|
|
|
|
|
Total Assets
|
|
|
$
|
|
|
$
|
|
Liabilities and Stockholders’ Deficit
|
|
|
|
|
|
|
|
Accounts payable
|
|
|
$
|
|
|
$
|
|
Accrued employee benefits
|
|
|
|
|
|
|
|
Accrued expenses
|
|
|
|
|
|
|
|
Contract liabilities
|
|
|
|
|
|
|
|
Related party notes payable - current
|
|
|
|
|
|
|
|
Notes payable - current
|
|
|
|
|
|
|
|
Embedded derivative liability
|
|
|
|
|
|
|
|
Patent installment payable - current
|
|
|
|
|
|
|
|
Obligation to issue equity
|
|
|
|
|
|
|
|
Warrant liability
|
|
|
|
|
|
|
|
Income taxes payable
|
|
|
|
|
|
|
|
Related party convertible promissory notes - current
|
|
|
|
|
|
|
|
Other current liabilities
|
|
|
|
|
|
|
|
Total Current Liabilities
|
|
|
|
|
|
|
|
Notes payable, net of current portion
|
|
|
|
|
|
|
|
Term convertible notes, net of current portion
|
|
|
|
|
|
|
|
Related party convertible promissory notes, net of current portion
|
|
|
|
|
|
|
|
Earnout liability
|
|
|
|
|
|
|
|
Stock-based compensation liability
|
|
|
|
|
|
|
|
Patent installment payable, net of current portion
|
|
|
|
|
|
|
|
Deferred income taxes
|
|
|
|
|
|
|
|
Other liabilities
|
|
|
|
|
|
|
|
Total Liabilities
|
|
|
|
|
|
|
|
Commitments and Contingencies (Note 16)
|
|
|
|
|
|
|
|
Stockholders’ Equity
|
|
|
|
|
|
|
|
Preferred stock, $
|
|
|
|
|
|
|
|
Series B Preferred Stock, $
|
|
|
|
|
|
|
|
Series C Preferred Stock, $
|
|
|
|
|
|
|
|
Common Stock, $
|
|
|
|
|
|
|
|
Additional paid-in capital
|
|
|
|
|
|
|
|
Accumulated other comprehensive (loss) gain
|
|
|
(
|
|
|
|
|
Accumulated deficit
|
|
|
(
|
|
|
(
|
|
Total Innventure, Inc., Stockholders’ Equity
|
|
|
|
|
|
|
|
Non-controlling interest
|
|
|
|
|
|
|
|
Total Stockholders’ Equity
|
|
|
|
|
|
|
|
Total Liabilities and Stockholders’ Equity
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||||||
|
|
|
|
Three months ended
|
|
|
Six months ended
|
||||||
|
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
Revenue
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill impairment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Operating Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from Operations
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-operating (Expense) and Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Net gain (loss) on investments
|
|
|
|
|
|
(
|
|
|
|
|
|
|
|
Net gain (loss) on investments – due to related
parties
|
|
|
|
|
|
|
|
|
|
|
|
(
|
|
Change in fair value of financial liabilities
|
|
|
|
|
|
|
|
|
|
|
|
(
|
|
Equity method investment (loss) income
|
|
|
(
|
|
|
|
|
|
(
|
|
|
|
|
Realized gain on conversion of available for sale
investment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on extinguishment of debt
|
|
|
(
|
|
|
|
|
|
(
|
|
|
|
|
Loss on extinguishment of related party debt
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
Loss on conversion of promissory notes
|
|
|
|
|
|
|
|
|
|
|
|
(
|
|
Miscellaneous other expense
|
|
|
(
|
|
|
|
|
|
(
|
|
|
|
|
Total Non-operating (Expense) Income
|
|
|
(
|
|
|
(
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Income tax benefit
|
|
|
(
|
|
|
|
|
|
(
|
|
|
|
|
Net Loss
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Less: net loss attributable to Non-redeemable
non-controlling interest
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Net Loss Attributable to
Innventure, Inc. Stockholders / Innventure LLC Unitholders
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted loss per share
|
|
|
$(
|
|
|
|
|
|
$(
|
|
|
|
|
Basic and diluted weighted average common shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income, net of taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain (loss) on available for sale debt
securities - related party
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
Reclassification of realized gain on conversion of
available for sale investments
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
Total other comprehensive income, net of taxes
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive loss, net of taxes
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Less: comprehensive loss attributable to
Non-redeemable non-controlling interest
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Net Comprehensive Loss
Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class B
Preferred
|
|
|
Class B-1
Preferred
|
|
|
Class A
|
|
|
Class C
|
|
|
Accumulated
Deficit
|
|
|
Non-
Controlling
Interest
|
|
|
Total (Deficit)
Equity
|
|
December 31, 2023
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
|
$
|
|
|
$(
|
|
Net loss
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Units issued to non-controlling interest
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Issuance of preferred units, net of issuance costs
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
Unit-based compensation
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
Issuance of units to non-controlling interest in
exchange of convertible promissory notes
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Accretion of redeemable units to redemption value
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
(
|
|
March 31, 2024
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
|
$
|
|
|
$(
|
|
Net loss
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Units issued to non-controlling interest
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Issuance of preferred units, net of issuance costs
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
Unit-based compensation
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
Accretion of redeemable units to redemption value
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
(
|
|
June 30, 2024
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
|
$
|
|
|
$(
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
|
|
|
|
Stockholders’ Equity
|
|
|
Mezzanine Equity
|
|||||||||||||||||||||||||||||||||
|
|
|
|
Series B
Preferred Stock
|
|
|
Series C
Preferred Stock
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock
|
||||||||||||
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Additional
Paid-In
Capital
|
|
|
Accumulated
Deficit
|
|
|
Accumulated
OCI
|
|
|
Non-
Controlling
Interest
|
|
|
Total
Stockholders’
Equity
|
|
|
Shares
|
|
|
Amount
|
|
December 31, 2024
|
|
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
$
|
|
Net loss
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
(
|
|
|
(
|
|
|
—
|
|
|
—
|
|
Series B Preferred Stock buyback
|
|
|
(
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
—
|
|
Series B Preferred Stock issued for paid-in-kind
dividends
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
Issuance of common shares, net of issuance costs
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
Vesting of earnout shares
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
Other comprehensive gain, net of taxes
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
—
|
|
Conversion of related party notes
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Issuance of Series C Preferred Stock, net
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Non-controlling interest issued and related transfers
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
Distributions to Stockholders
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
—
|
|
Stock-based compensation
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
Accrued preferred dividends
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
(
|
|
March 31, 2025
|
|
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
|
$(
|
|
|
$
|
|
|
$
|
|
|
|
|
|
$
|
|
Net loss
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
—
|
|
|
(
|
|
|
(
|
|
|
—
|
|
|
—
|
|
Issuance of common shares, net of issuance costs
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
Other comprehensive gain, net of taxes
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
Non-controlling interest issued and related transfers
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
(
|
|
|
|
|
|
—
|
|
|
—
|
|
Stock-based compensation
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
Accrued preferred dividends
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
Conversion to Common Stock
|
|
|
(
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
(
|
|
|
(
|
|
Transfer of Series C Preferred Stock from Mezzanine
equity to Stockholders’ equity
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
(
|
|
|
(
|
|
June 30, 2025
|
|
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
|
$(
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
|
Six months ended
June 30, 2025
|
|
|
Six months ended
June 30, 2024
|
|
Cash Flows Used in Operating Activities
|
|
|
|
|
|
|
|
Net loss
|
|
|
$(
|
|
|
$(
|
|
Adjustments to reconcile net
loss to net cash and cash equivalents used in operating activities:
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
|
|
|
|
|
Interest income on debt securities - related party
|
|
|
(
|
|
|
|
|
Change in fair value of financial liabilities
|
|
|
(
|
|
|
|
|
Change in fair value of payables due to related parties
|
|
|
|
|
|
|
|
Non-cash interest expense on notes payable
|
|
|
|
|
|
|
|
Net gain on investments
|
|
|
|
|
|
(
|
|
Equity method investment gain (loss)
|
|
|
|
|
|
(
|
|
Realized gain on conversion of available for sale investments
|
|
|
(
|
|
|
|
|
Loss on extinguishment of debt
|
|
|
|
|
|
|
|
Loss on extinguishment of related party debt
|
|
|
3,538
|
|
|
—
|
|
Loss on conversion of promissory notes
|
|
|
|
|
|
|
|
Deferred income taxes
|
|
|
(
|
|
|
|
|
Depreciation and amortization
|
|
|
|
|
|
|
|
Goodwill impairment
|
|
|
|
|
|
|
|
Payment of patent installment
|
|
|
(
|
|
|
|
|
Other costs
|
|
|
|
|
|
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(
|
|
|
|
|
Prepaid expenses and other current assets
|
|
|
(
|
|
|
(
|
|
Inventory
|
|
|
(
|
|
|
(
|
|
Accounts payable
|
|
|
|
|
|
|
|
Accrued employee benefits
|
|
|
|
|
|
|
|
Accrued expenses
|
|
|
|
|
|
|
|
Stock-based compensation liability
|
|
|
(
|
|
|
|
|
Income taxes payable
|
|
|
|
|
|
|
|
Other current liabilities
|
|
|
(
|
|
|
(
|
|
Contract liabilities
|
|
|
|
|
|
|
|
Net Cash Used in Operating Activities
|
|
|
(
|
|
|
(
|
|
|
|
|
|
|
|
|
|
Cash Flows Used in Investing Activities
|
|
|
|
|
|
|
|
Investment in available-for-sale debt securities - equity method
investee
|
|
|
(
|
|
|
|
|
Loans to equity method investee
|
|
|
|
|
|
(
|
|
Acquisition of property, plant and equipment
|
|
|
(
|
|
|
(
|
|
Proceeds from sale of investments
|
|
|
|
|
|
|
|
Net Cash Used in Investing Activities
|
|
|
(
|
|
|
(
|
|
|
|
|
|
|
|
|
|
Cash Flows Provided by Financing Activities
|
|
|
|
|
|
|
|
Proceeds from issuance of equity, net of issuance costs
|
|
|
|
|
|
|
|
Proceeds from the issuance of equity to
non-controlling interest, net of issuance costs
|
|
|
|
|
|
|
|
Proceeds from the issuance of related party convertible promissory notes
|
|
|
|
|
|
|
|
Proceeds from the issuance of term convertible notes
|
|
|
|
|
|
|
|
Proceeds from issuance of debt securities, net of issuance costs
|
|
|
|
|
|
|
|
Payment of debts
|
|
|
(
|
|
|
(
|
|
Distributions to stockholders and other
|
|
|
(
|
|
|
|
|
Net Cash Flows Provided by Financing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash
|
|
|
|
|
|
(
|
|
Cash, Cash Equivalents and Restricted Cash Beginning of period
|
|
|
|
|
|
|
|
Cash, Cash Equivalents and Restricted Cash End of period
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
|
Six months ended
June 30, 2025
|
|
|
Six months ended
June 30, 2024
|
|
Supplemental Cash Flow Information
|
|
|
|
|
|
|
|
Cash paid for interest
|
|
|
$
|
|
|
$
|
|
Supplemental Disclosure of Noncash Financing
Information
|
|
|
|
|
|
|
|
Accretion of redeemable units to redemption value
|
|
|
|
|
|
|
|
Issuance of units to non-controlling interest in
exchange of convertible promissory notes
|
|
|
|
|
|
|
|
Conversion of working capital loans to equity method
investee into investments in debt securities - related party
|
|
|
|
|
|
|
|
Extinguishment of debt with Series C Preferred Stock
|
|
|
|
|
|
|
|
Contribution of Series C Preferred Stock to equity method investee
|
|
|
|
|
|
|
|
Conversion of AFX available-for-sale term loan into
equity method investments
|
|
|
|
|
|
|
|
Issuance of common stock as repayment of convertible debt
|
|
|
|
|
|
|
|
Issuance of stock in exchange for services
|
|
|
|
|
|
|
|
Conversion of preferred stock into common stock
|
|
|
|
|
|
|
|
Transfer of Series C Preferred Stock from Mezzanine
to Stockholders’ equity
|
|
|
|
|
|
|
|
Embedded derivative in association with Convertible Debentures
|
|
|
|
|
|
|
|
Equity reallocation between non-controlling interest
and additional paid-in capital
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2025
|
|
|
December 31, 2024
|
|
Equity-method investments
|
|
|
$
|
|
|
$
|
|
Investment in debt securities - AFS
|
|
|
|
|
|
|
|
Total Investments
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2025
|
|
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
|
Total
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in debt security - AFS
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnout liability
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
2024 WTI Warrant liability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025 WTI Warrant liability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private placement warrant liability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Embedded derivative liability - Convertible Debentures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2024
|
|
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
|
Total
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in debt security - AFS
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnout liability
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
2024 WTI Warrant liability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private placement warrant liability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Embedded
derivative liability -
convertible
promissory notes
|
|
|
Investment in debt
securities - AFS
|
|
|
Earnout
liability
|
|
|
2024 WTI
Warrant
liability
|
|
|
2025 WTI
Warrant
liability
|
|
|
Embedded
derivative liability -
Convertible
Debentures
|
|
Balance as of January 1, 2024
(Predecessor)
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$—
|
|
Settlement
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
Change in fair value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
Balance as of June 30, 2024
(Predecessor)
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of January 1, 2025
(Successor)
|
|
|
$—
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Additions
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Settlement
|
|
|
—
|
|
|
(
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
Change in fair value
|
|
|
—
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
|
|
|
|
|
Balance as of June 30, 2025
(Successor)
|
|
|
$—
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal Valuation
Techniques
|
|
|
Unobservable
Inputs
|
|
|
June 30,
2025
|
|
|
December 31, 2024
|
|
Investment in debt securities - AFS:
|
||||||||||||
|
|
|
|
Black-Scholes model
|
|
|
Volatility
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time to liquidity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount for lack of marketability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average cost of capital
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free rate
|
|
|
|
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
|
AeroFlexx yield
|
|
|
|
|
|
|
|
Earnout Shares:
|
||||||||||||
|
|
|
|
Geometric Brownian Motion
|
|
|
Term
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock price
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
Volatility
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free rate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue risk premium
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue volatility
|
|
|
|
|
|
|
|
2024 WTI Warrants:
|
||||||||||||
|
|
|
|
Geometric Brownian Motion
|
|
|
Stock price
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
Stock price volatility
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit spread
|
|
|
|
|
|
|
|
2025 WTI Warrants:
|
||||||||||||
|
|
|
|
Geometric Brownian Motion
|
|
|
Stock price
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
Stock price volatility
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit spread
|
|
|
|
|
|
|
|
Embedded derivative liability - Convertible
Debentures:
|
||||||||||||
|
|
|
|
Discounted Cash Flows
|
|
|
Debt Yield
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maturities
|
|
|
June 30, 2025
|
|
|
Interest Rates
|
|
|
December 31, 2024
|
|
|
Interest Rates
|
|
Series 1 promissory notes
|
|
|
2025 - 2026
|
|
|
$
|
|
|
|
|
|
$
|
|
|
|
|
Related party notes
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
Convertible debentures
|
|
|
2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term convertible notes
|
|
|
2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Related party convertible notes
|
|
|
2025 - 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WTI Facility
|
|
|
2028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Notes Payable
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: unamortized debt discount
|
|
|
|
|
|
(
|
|
|
|
|
|
(
|
|
|
|
|
Less: current portion of related party notes payable
|
|
|
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
Less: current portion of related party convertible
notes
|
|
|
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
Less: current portion of notes payable
|
|
|
|
|
|
(
|
|
|
|
|
|
(
|
|
|
|
|
Total Long-term Notes
|
|
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
Year Ending December 31,
|
|
|
Amount
|
|
2025 (remaining 6 months)
|
|
|
$
|
|
2026
|
|
|
|
|
2027
|
|
|
|
|
2028
|
|
|
|
|
Total Debt
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
Three months ended
|
|
|
Six months ended
|
||||||
|
|
|
|
Interest Rate
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
Principal amount of 1st extension promissory notes
|
|
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Principal amount of 2nd extension promissory notes
|
|
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
Three months ended
|
|
|
Six months ended
|
||||||
|
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
Interest attributable to contractual interest
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||||||
|
|
|
|
Three months ended
|
|
|
Six months ended
|
||||||
|
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
Total interest expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||||||
|
|
|
|
Three months ended
|
|
|
Six months ended
|
||||||
|
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
Interest attributable to contractual interest
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Interest attributable to amortization of issuance
costs and discounts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total interest expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||||||
|
|
|
|
Three months ended
|
|
|
Six months ended
|
||||||
|
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
Interest attributable to amortization of issuance costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total interest expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2025
|
|
|
December 31, 2024
|
|
Raw materials
|
|
|
$
|
|
|
$
|
|
Work in process
|
|
|
|
|
|
|
|
Finished goods
|
|
|
|
|
|
|
|
Total inventories
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2025
|
|
|
December 31, 2024
|
|
Leasehold improvements
|
|
|
$
|
|
|
$
|
|
Machinery & equipment
|
|
|
|
|
|
|
|
Computers & office equipment
|
|
|
|
|
|
|
|
Construction in progress
|
|
|
|
|
|
|
|
Property, plant and equipment, gross
|
|
|
|
|
|
|
|
Less: Accumulated depreciation
|
|
|
(
|
|
|
(
|
|
Property, plant and equipment, net
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2024
|
|
|
$
|
|
Impairment
|
|
|
(
|
|
Other
|
|
|
|
|
Balance as of June 30, 2025
|
|
|
$
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
June 30, 2025
|
|
|
December 31, 2024
|
|||||||||||||||
|
Intangible Asset
|
|
|
Weighted-Average
Amortization Period
Remaining (Years)
|
|
|
Gross Carrying
Amount
|
|
|
Accumulated
Amortization
|
|
|
Net Carrying
Amount
|
|
|
Gross Carrying
Amount
|
|
|
Accumulated
Amortization
|
|
|
Net Carrying
Amount
|
|
Trade names
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
|
|
|
|
$(
|
|
|
$
|
|
Customer relationships
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
|
|
|
|
$(
|
|
|
$
|
|
Developed technology
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
|
|
|
|
$(
|
|
|
$
|
|
Other finite-lived intangible assets
|
|
|
|
|
|
|
|
|
(
|
|
|
|
|
|
|
|
|
|
|
|
$
|
|
Total intangible assets
|
|
|
|
|
|
$
|
|
|
$(
|
|
|
$
|
|
|
$
|
|
|
$(
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization Expense
|
|
2025 (excluding the first six months of fiscal year 2025)
|
|
|
$
|
|
2026
|
|
|
|
|
2027
|
|
|
|
|
2028
|
|
|
|
|
2029
|
|
|
|
|
2030 and thereafter
|
|
|
|
|
Total
|
|
|
$
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Public
Warrants
|
|
|
Number of Private
Warrants
|
|
|
Number of 2024 WTI
Warrants
|
|
|
Number of 2025 WTI
Warrants
|
|
Outstanding, December 31, 2024
(Successor)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, June 30, 2025
(Successor)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
June 30, 2025
|
|
|
Six months ended
June 30, 2025
|
|
Numerator:
|
|
|
|
|
|
|
|
Net loss attributable to Innventure, Inc., shareholders
|
|
|
$(
|
|
|
$(
|
|
Less: Cumulative earnings to participating securities
|
|
|
|
|
|
|
|
Undistributed loss for participating securities
|
|
|
(
|
|
|
(
|
|
Less: Undistributed loss attributable to participating securities
|
|
|
|
|
|
|
|
Net loss attributable to common shareholders, basic
and diluted
|
|
|
$(
|
|
|
$(
|
|
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
|
Weighted average number of units outstanding, basic and diluted
|
|
|
|
|
|
|
|
Net loss per share attributable
to common shareholders, basic and diluted
|
|
|
$(
|
|
|
$(
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
June 30, 2025
|
|
|
Six months ended
June 30, 2025
|
|
Public warrants
|
|
|
|
|
|
|
|
Private placement warrants
|
|
|
|
|
|
|
|
2024 WTI Warrants
|
|
|
|
|
|
|
|
Convertible Debentures
|
|
|
|
|
|
|
|
2025 WTI Warrants
|
|
|
|
|
|
|
|
Series B Preferred Stock
|
|
|
|
|
|
|
|
Series C Preferred Stock
|
|
|
|
|
|
|
|
Share options
|
|
|
|
|
|
|
|
RSUs
|
|
|
|
|
|
|
|
SARs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
Years Ending December 31,
|
|
|
Amount
|
|
2025 (excluding the first six months of fiscal year 2025)
|
|
|
$
|
|
2026
|
|
|
|
|
2027
|
|
|
|
|
2028
|
|
|
|
|
2029
|
|
|
|
|
Thereafter
|
|
|
|
|
Total
|
|
|
$
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||||||
|
|
|
|
Three months ended
|
|
|
Six months ended
|
||||||
|
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
Revenue
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Interest income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Employee costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Facilities, equipment & supplies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outside services
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation expense *
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense (benefit)
|
|
|
(
|
|
|
|
|
|
(
|
|
|
|
|
Goodwill impairment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other **
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Expenses
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
Represents depreciation expense not already included in Cost of sales.
|
|
**
|
Other - change in fair value of financial liabilities, loss on conversion of promissory notes, travel and other miscellaneous
expenses.
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
Three months ended
|
|
|
Six months ended
|
||||||
|
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Elimination of management services provided to
Technology
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Consolidated Revenues
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||||||
|
|
|
|
Three months ended
|
|
|
Six months ended
|
||||||
|
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
|
June 30, 2025
(Successor)
|
|
|
June 30, 2024
(Predecessor)
|
|
Interest Expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Interest Expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Interest Income
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and Amortization Expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Depreciation and
Amortization Expense
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
Other
|
|
|
(
|
|
|
(
|
|
|
(
|
|
|
(
|
|
Consolidated Net Loss
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
|
$(
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Expenditures:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Capital Expenditures
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
Item 13.
|
Other Expenses of Issuance and Distribution
|
|
|
|
|
|
|
|
|
|
Amount to be paid
|
|
SEC registration fee
|
|
|
$11,177.02
|
|
Accounting fees and expenses
|
|
|
$ (1)
|
|
Legal fees and expenses
|
|
|
$(1)
|
|
Printing and miscellaneous expenses
|
|
|
$(1)
|
|
Total
|
|
|
$(1)
|
|
|
|
|
|
|
(1)
|
Fees and expenses (other than the SEC registration fee to be paid upon the filing of this registration statement) will depend on
the number and nature of any offerings of securities made pursuant to this registration statement, and cannot be estimated at this time. An estimate of the aggregate expenses in connection with the distribution of securities being
offered will be included in any applicable prospectus supplement.
|
|
Item 14.
|
Indemnification of Directors and Officers
|
TABLE OF CONTENTS
|
Item 15.
|
Recent Sales of Unregistered Securities
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
Item 16.
|
Exhibits
|
|
|
|
|
|
|
Exhibit
Number
|
|
|
Description of Exhibits
|
|
2.1+
|
|
|
Business Combination Agreement, dated as of October 24, 2023, by and
among Learn SPAC Holdco, Inc., Learn CW Investment Corporation, LCW Merger Sub, Inc., Innventure LLC and Innventure Merger Sub, LLC (incorporated by reference to Annex A to Innventure, Inc.’s Registration Statement on Form S-4 filed
with the SEC on September 6, 2024).
|
|
3.1
|
|
|
Amended and Restated Certificate of Incorporation of Innventure, Inc.,
filed with the Secretary of State of Delaware on October 2, 2024 (incorporated by reference to Exhibit 3.1 to Innventure Inc.’s Current Report on Form 8-K filed with the SEC on October 9, 2024).
|
|
3.2
|
|
|
By-laws of Innventure, Inc. (incorporated by reference to Exhibit 3.2 to
Innventure Inc.’s Current Report on Form 8-K filed with the SEC on October 9, 2024).
|
|
3.3
|
|
|
Certificate of Designation of Series B Preferred Stock, dated October 2,
2024, of Innventure, Inc. (incorporated by reference to Exhibit 3.3 to Innventure Inc.’s Quarterly Report on Form 10-Q filed with the SEC on May 15, 2025).
|
|
3.4
|
|
|
Certificate of Designation of Series C Preferred Stock, dated March 24,
2025, of Innventure, Inc. (incorporated by reference to Exhibit 3.1 to Innventure Inc.’s Current Report on Form 8-K filed with the SEC on March 25, 2025).
|
|
4.1
|
|
|
Form of Innventure LLC Series 1 Promissory Note (incorporated by
reference to Exhibit 4.3 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
4.2
|
|
|
Form of Accelsius Holdings LLC Convertible Promissory Note (incorporated
by reference to Exhibit 4.4 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
4.3
|
|
|
Secured Convertible Note and Warrant Purchase Agreement, dated as of
June 3, 2021, by and among Innventus ESG Fund I, L.P., AeroFlexx, LLC, and the Investors party thereto (incorporated by reference to Exhibit 4.5 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6,
2024).
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
Exhibit
Number
|
|
|
Description of Exhibits
|
|
4.4
|
|
|
Amended and Restated Secured Convertible Promissory Note and Warrant
Purchase Agreement, dated as of July 31, 2021, by and among Innventus ESG Fund I, L.P., AeroFlexx, LLC, and the Investors party thereto (incorporated by reference to Exhibit 4.6 to Innventure, Inc.’s Registration Statement on Form S-4
filed with the SEC on September 6, 2024).
|
|
4.5
|
|
|
Form of Innventure Class B Warrant Cashless Exercise Description and
Acknowledgment Letter (incorporated by reference to Exhibit 4.8 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
4.6^
|
|
|
Warrant to Acquire Securities of Innventure, Inc., dated October 22,
2024, issued to WTI Fund X, LLC (incorporated by reference to Exhibit 4.1 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on October 23, 2024).
|
|
4.7^
|
|
|
Warrant to Acquire Securities of Innventure, Inc., dated October 22,
2024, issued to WTI Fund XI, LLC (incorporated by reference to Exhibit 4.2 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on October 23, 2024).
|
|
4.8^
|
|
|
First Convertible Debenture, issued to YA II PN, Ltd., dated April 14,
2025 (incorporated by reference to Exhibit 4.1 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on April 14, 2025).
|
|
4.9^
|
|
|
Warrant to Acquire Securities of Innventure, Inc., issued to WTI Fund X,
LLC on April 14, 2025 (incorporated by reference to Exhibit 4.2 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC April 14, 2025).
|
|
4.10^
|
|
|
Warrant to Acquire Securities of Innventure, Inc., issued to WTI Fund XI,
LLC on April 14, 2025 (incorporated by reference to Exhibit 4.3 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on April 14, 2025).
|
|
4.11^
|
|
|
Second Convertible Debenture, issued to YA II PN, Ltd., dated May 15,
2025 (incorporated by reference to Exhibit 4.1 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on May 15, 2025).
|
|
4.12
|
|
|
Registration and Shareholder Rights Agreement, dated October 12, 2021, by
and among Learn CW Investment Corporation, the Sponsor and certain other security holders named therein (incorporated by reference to Exhibit 10.4 to Learn CW Investment Corporation’s Current Report on Form 8-K filed with the SEC on
October 14, 2021).
|
|
4.13^
|
|
|
Third Convertible Debenture, issued to YA II PN, Ltd., dated
September 15, 2025 (incorporated by reference to Exhibit 4.1 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on September 16, 2025).
|
|
4.14
|
|
|
Form of Series A Warrant (incorporated by reference to Exhibit 4.1 to
Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on October 6, 2025).
|
|
5.1*
|
|
|
Opinion of Jones Day.
|
|
10.1#
|
|
|
Offer Letter, dated September 7, 2023, between David Yablunosky and
Innventure LLC (incorporated by reference to Exhibit 10.8 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.2
|
|
|
Loan and Security Agreement, dated as of March 30, 2023, among Innventure
LLC, Accelsius Holdings LLC, and Accelsius LLC (incorporated by reference to Exhibit 10.6 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.3
|
|
|
Class D Preferred Unit Purchase Agreement, by and between Innventus ESG,
AeroFlexx, and the Investors party thereto, dated as of November 10, 2021 (incorporated by reference to Exhibit 10.12 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.4
|
|
|
Series I Convertible Note Purchase Agreement, dated as of August 18,
2022, by and among Accelsius, Innventus ESG Fund I L.P. and the other parties thereto (incorporated by reference to Exhibit 10.13 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.5
|
|
|
Amended and Restated Series I Convertible Note Purchase Agreement, dated
as of June 2, 2023, by and among Accelsius, Innventus ESG Fund I L.P. and the other parties thereto (incorporated by reference to Exhibit 10.14 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6,
2024).
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
Exhibit
Number
|
|
|
Description of Exhibits
|
|
10.6
|
|
|
Class A Series 2 Unit Purchase Agreement, dated as of July 19, 2022, by
and among Innventus ESG Fund I, L.P., Accelsius Holdings LLC, and the Investors party thereto (incorporated by reference to Exhibit 10.15 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.7
|
|
|
Letter Agreement, dated October 7, 2021, among Learn CW Investment
Corporation and its officers, directors, director nominees and the Sponsor (incorporated by reference to Exhibit 10.1 to Learn CW Investment Corporation’s Current Report on Form 8-K filed with the SEC on October 14, 2021).
|
|
10.8#
|
|
|
Contractor Agreement for Services, effective November 16, 2023, by and
between Innventure LLC and Sugar Grove Ventures, LLC (incorporated by reference to Exhibit 10.8 to Innventure, Inc.’s Annual Report on Form 10-K filed with the SEC on April 14, 2025).
|
|
10.9#
|
|
|
Employment Agreement, dated as of March 5, 2024, by and between
Innventure LLC and Suzanne Niemeyer (incorporated by reference to Exhibit 10.24 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.10
|
|
|
Management Services Agreement, dated January 22, 2021, by and between
Innventure LLC and L1FE Management Limited (incorporated by reference to Exhibit 10.25 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.11
|
|
|
Amendment to Management Services Agreement, dated October 1, 2021, by and
between Innventure LLC and L1FE Management Limited (incorporated by reference to Exhibit 10.26 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.12
|
|
|
Summary of the Statement of Work, effective as of April 1, 2018, between
Innventure LLC and Corporate Development Group LLC (incorporated by reference to Exhibit 10.27 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.13
|
|
|
First Amendment to Loan and Security Agreement, dated December 13, 2023,
among Innventure LLC, Accelsius Holdings LLC, and Accelsius LLC (incorporated by reference to Exhibit 10.31 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.14**+
|
|
|
Patent Purchase Agreement, dated May 27, 2022, between Nokia
Technologies, OY, Nokia Solutions and Networks, OY, and Accelsius Holdings LLC (incorporated by reference to Exhibit 10.32 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.15
|
|
|
Patent and Know How License Agreement, dated February 15, 2018, between
Air Assist LLC and The Procter & Gamble Company (incorporated by reference to Exhibit 10.34 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.16**
|
|
|
Amended and Restated Patent and Know-How License Agreement, dated as of
October 25, 2021, by and between the Procter & Gamble Company and AeroFlexx, LLC (incorporated by reference to Exhibit 10.28 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on January 6, 2024).
|
|
10.17
|
|
|
Aircraft Time-Sharing Agreement, dated May 6, 2024, by and between
Innventure LLC and Sugar Grove Ventures LLC (incorporated by reference to Exhibit 10.37 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.18
|
|
|
Aircraft Time-Sharing Agreement, dated May 6, 2024, by and between
Innventure LLC and Corporate Development Group LLC (incorporated by reference to Exhibit 10.38 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.19
|
|
|
Second Amendment to Loan and Security Agreement, dated April 10, 2024,
among Innventure LLC, Accelsius Holdings LLC, and Accelsius LLC (incorporated by reference to Exhibit 10.41 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.20
|
|
|
Third Amendment to Loan and Security Agreement, dated July 1, 2024, among
Innventure LLC, Accelsius Holdings LLC, and Accelsius LLC (incorporated by reference to Exhibit 10.42 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
Exhibit
Number
|
|
|
Description of Exhibits
|
|
10.21
|
|
|
Amendment to the Statement of Work, effective October 1, 2021, between
Innventure LLC and Corporate Development Group LLC (incorporated by reference to Exhibit 10.39 to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.22
|
|
|
Warrant Agreement, dated October 12, 2021, between Learn CW Investment
Corporation and American Stock Transfer & Trust Company, LLC, as warrant agent (incorporated by reference to Exhibit 4.1 to Learn CW Investment Corporation’s Current Report on Form 8-K filed with the SEC on October 14, 2021).
|
|
10.23
|
|
|
Warrant Assumption Agreement, dated October 2, 2024, by and among Learn
CW Investment Corporation, Innventure, Inc. (f/k/a Learn SPAC HoldCo, Inc.) and Equiniti Trust Company, LLC (f/k/a American Stock Transfer & Stock Company, LLC), as warrant agent (incorporated by reference to Exhibit 10.2 to
Innventure Inc.’s Current Report on Form 8-K filed with the SEC on October 9, 2024).
|
|
10.24
|
|
|
Amended and Restated Registration Rights Agreement, dated October 2,
2024, by and among Innventure, Inc., Learn CW Investment Corporation, CWAM LC Sponsor LLC and the undersigned parties listed thereto (incorporated by reference to Exhibit 10.3 to Innventure Inc.’s Current Report on Form 8-K filed with
the SEC on October 9, 2024).
|
|
10.25
|
|
|
Amended & Restated Investor Rights Agreement, dated October 2, 2024,
by and among Innventure, Inc., and the undersigned parties listed thereto (incorporated by reference to Exhibit 10.4 to Innventure Inc.’s Current Report on Form 8-K filed with the SEC on October 9, 2024).
|
|
10.26#
|
|
|
Form of Indemnification Agreement (incorporated by reference to
Exhibit 10.7 to Innventure Inc.’s Current Report on Form 8-K filed with the SEC on October 9, 2024).
|
|
10.27#
|
|
|
Innventure, Inc. 2024 Equity and Incentive Compensation Plan
(incorporated by reference to Annex K to Innventure, Inc.’s Registration Statement on Form S-4 filed with the SEC on September 6, 2024).
|
|
10.28^
|
|
|
Form of Investment Agreement by and among Innventure, Inc. and the
purchasers listed on Schedule I thereto (incorporated by reference to Exhibit 10.9 to Innventure Inc.’s Current Report on Form 8-K filed with the SEC on October 9, 2024).
|
|
10.29^
|
|
|
Loan and Security Agreement, dated October 22, 2024, by and among
Innventure LLC, WTI Fund X, Inc. and WTI Fund XI, Inc. (incorporated by reference to Exhibit 10.1 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on October 23, 2024).
|
|
10.30^
|
|
|
Supplement to the Loan and Security Agreement, dated October 22, 2024, by
and among Innventure LLC, WTI Fund X, Inc. and WTI Fund XI, Inc. (incorporated by reference to Exhibit 10.2 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on October 23, 2024).
|
|
10.31#
|
|
|
Form of Notice of Grant of Restricted Stock Units and Restricted Stock
Units Agreement for Executive Officers (incorporated by reference to Exhibit 10.1 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on December 13, 2024).
|
|
10.32#
|
|
|
Form of Notice of Grant of Nonqualified Stock Option and Nonqualified
Stock Option Agreement for Executive Officers (incorporated by reference to Exhibit 10.2 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on December 13, 2024).
|
|
10.33#
|
|
|
Form of Notice of Grant of Appreciation Rights (incorporated by reference
to Exhibit 10.35 to Innventure, Inc.’s Annual Report on Form 10-K filed with the SEC on April 14, 2025).
|
|
10.34#
|
|
|
Form of Notice of Grant of Cash-Settled Appreciation Rights (incorporated
by reference to Exhibit 10.36 to Innventure, Inc.’s Annual Report on Form 10-K filed with the SEC on April 14, 2025).
|
|
10.35
|
|
|
Standby Equity Purchase Agreement, by and between Innventure, Inc. and YA
II PN, Ltd., dated October 24, 2023 (incorporated by reference to Exhibit 10.1 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on March 25, 2025).
|
|
10.36^
|
|
|
Form of Series C Purchase Agreement for U.S. Investors (incorporated by
reference to Exhibit 10.2 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on March 25, 2025).
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
Exhibit
Number
|
|
|
Description of Exhibits
|
|
10.37^
|
|
|
Form of Series C Purchase Agreement for Ex-U.S. Investors (incorporated
by reference to Exhibit 10.3 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on March 25, 2025).
|
|
10.38^
|
|
|
Securities Purchase Agreement, by and between Innventure, Inc. and YA II
PN, Ltd., dated March 26, 2025 (incorporated by reference to Exhibit 10.1 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on March 26, 2025).
|
|
10.39
|
|
|
Global Guaranty Agreement by Innventure, LLC, dated April 14, 2025
(incorporated by reference to Exhibit 10.1 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on April 14, 2025).
|
|
10.40
|
|
|
Registration Rights Agreement, dated April 14, 2025, between Innventure,
Inc. and YA II PN, Ltd. (incorporated by reference to Exhibit 10.2 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on April 14, 2025).
|
|
10.41#
|
|
|
Innventure, Inc. 2025 Short-Term Incentive Plan (incorporated by
reference to Exhibit 10.43 to Innventure, Inc.’s Annual Report on Form 10-K filed with the SEC on April 14, 2025).
|
|
10.42
|
|
|
Form of Voting Agreement (incorporated by reference to Exhibit 10.1 to
Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on May 15, 2025).
|
|
10.43
|
|
|
Amendment to Convertible Debentures, dated as of June 4, 2025, by and
between Innventure, Inc. and YA II PN, Ltd. (incorporated by reference to Exhibit 10.1 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on June 4, 2025).
|
|
10.44
|
|
|
Form of Term Convertible Note (incorporated by reference to Exhibit 10.1
to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on July 1, 2025).
|
|
10.45
|
|
|
Letter Agreement, dated as of June 26, 2025, by and among Innventure,
Inc., Innventure LLC and Accelsius Holdings LLC (incorporated by reference to Exhibit 10.2 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on July 1, 2025).
|
|
10.46
|
|
|
Form of Bridge Convertible Note (incorporated by reference to
Exhibit 10.3 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on July 1, 2025).
|
|
10.47#
|
|
|
Form of Amendment to Stock Appreciation Right Award Agreement
(incorporated by reference to Exhibit 10.4 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on July 1, 2025).
|
|
10.48^**
|
|
|
Amended and Restated Technology License and Know-How Agreement, dated
June 30, 2025, among Accelsius, LLC, Innventure LLC (solely as specifically set forth therein), Nokia Technologies Oy, Nokia Solutions and Networks Oy, and Nokia of America Corporation (incorporated by reference to Exhibit 10.1 to
Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on July 2, 2025).
|
|
10.49#
|
|
|
Form of Notice of Grant of Restricted Stock Units and Restricted Stock
Units Agreement for Directors (incorporated by reference to Exhibit 10.10 to Innventure, Inc.’s Quarterly Report on Form 10-Q filed with the SEC on August 14, 2025).
|
|
10.50^
|
|
|
Securities Purchase Agreement, dated as of September 15, 2025, by and
between Innventure, Inc. and YA II PN, Ltd. (incorporated by reference to Exhibit 10.1 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on September 16, 2025).
|
|
10.51
|
|
|
Global Guaranty Agreement, dated as of September 15, 2025, by Innventure
LLC (incorporated by reference to Exhibit 10.2 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on September 16, 2025).
|
|
10.52
|
|
|
Registration Rights Agreement, dated as of September 15, 2025, between
Innventure, Inc. and YA II PN, Ltd. (incorporated by reference to Exhibit 10.3 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on September 16, 2025).
|
|
10.53
|
|
|
Amendment to Convertible Debentures, dated as of September 15, 2025, by
and between Innventure, Inc. and YA II PN, Ltd. (incorporated by reference to Exhibit 10.4 to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on September 16, 2025).
|
|
10.54#*
|
|
|
Amended and Restated Innventure, Inc. Non-Management Director
Compensation Plan, dated as of June 25, 2025.
|
|
10.55^
|
|
|
Form of Subscription Agreement (incorporated by reference to Exhibit 10.1
to Innventure, Inc.’s Current Report on Form 8-K filed with the SEC on October 6, 2025).
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
Exhibit
Number
|
|
|
Description of Exhibits
|
|
10.56*
|
|
|
Fourth Amendment to Loan and Security Agreement, dated April 1, 2025,
among Innventure LLC, Accelsius Holdings LLC, and Accelsius LLC.
|
|
10.57*
|
|
|
Fifth Amendment to Loan and Security Agreement, dated September 18, 2025,
among Innventure LLC, Accelsius Holdings LLC, and Accelsius LLC.
|
|
21.1
|
|
|
Subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1
to Innventure, Inc.’s Annual Report on Form 10-K filed with the SEC on April 14, 2025).
|
|
23.1*
|
|
|
Consent of Jones Day (included in Exhibit 5.1).
|
|
23.2*
|
|
|
Consent of BDO USA P.C.
|
|
24.1*
|
|
|
Power of Attorney (included on the signature page hereto).
|
|
101.SCH*
|
|
|
Inline XBRL Taxonomy Extension Schema Document
|
|
101.CAL*
|
|
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF*
|
|
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB*
|
|
|
Inline XBRL Taxonomy Extension Lable Linkbase Document
|
|
101.PRE*
|
|
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
107*
|
|
|
Filing Fee Table
|
|
|
|
|
|
|
*
|
Filed herewith
|
|
**
|
Certain identified information has been excluded from this exhibit pursuant to Rule 601(b)(10) of Regulation S-K because it is
both (i) not material and (ii) is the type of information that the registrant treats as private or confidential.
|
|
†
|
The Registrant respectfully submits that it has filed a Confidential Treatment Request with the Commission with respect to this
exhibit.
|
|
+
|
Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant agrees to furnish
supplementally a copy of any omitted schedule or exhibit to the SEC upon request.
|
|
^
|
Certain schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. Innventure, Inc. agrees to furnish a copy of
any omitted schedule to the SEC upon request.
|
|
#
|
Indicates management contract or compensatory plan or arrangement.
|
|
Item 17.
|
Undertakings
|
|
(a)
|
The undersigned registrant hereby undertakes:
|
|
(1)
|
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
|
|
(i)
|
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
|
|
(ii)
|
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most
recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Filing
Fee Tables” in the effective registration statement.
|
|
(iii)
|
To include any material information with respect to the plan of distribution not previously disclosed in the registration
statement or any material change to such information in the registration statement.
|
|
(2)
|
That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be
deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the
|
TABLE OF CONTENTS
|
(3)
|
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at
the termination of the offering.
|
|
(4)
|
That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant
to Rule 424(b):
|
|
(i)
|
shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in
the registration statement; and
|
|
(ii)
|
other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be
deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to
such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.
|
|
(5)
|
That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the
initial distribution of the securities:
|
|
(i)
|
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to
Rule 424;
|
|
(ii)
|
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred
to by the undersigned registrant;
|
|
(iii)
|
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned
registrant or its securities provided by or on behalf of the undersigned registrant; and
|
|
(iv)
|
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
|
|
(b)
|
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and
controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as
expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director,
officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant
will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the
Securities Act of 1933 and will be governed by the final adjudication of such issue.
|
TABLE OF CONTENTS
|
|
|
|
|
|||
|
|
|
|
INNVENTURE, INC
|
|||
|
|
|
|
|
|
||
|
|
|
|
By:
|
|
|
/s/ Gregory W. Haskell
|
|
|
|
|
Name:
|
|
|
Gregory W. Haskell
|
|
|
|
|
Title:
|
|
|
Chief Executive Officer and Director
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature
|
|
|
Title
|
|
|
Date
|
|
|
|
|
|
|
|
|
|
/s/ Gregory W. Haskell
|
|
|
Chief Executive Officer and Director
(Principal Executive Officer)
|
|
|
October 23, 2025
|
|
Gregory W. Haskell
|
|
|||||
|
|
|
|
|
|
|
|
|
/s/ David Yablunosky
|
|
|
Chief Financial Officer and Director
(Principal Financial Officer and Principal
Accounting Officer)
|
|
|
October 23, 2025
|
|
David Yablunosky
|
|
|||||
|
|
|
|
|
|
|
|
|
/s/ Michael Otworth
|
|
|
Executive Chairman and Director
|
|
|
October 23, 2025
|
|
Michael Otworth
|
|
|||||
|
|
|
|
|
|
|
|
|
/s/ Suzanne Niemeyer
|
|
|
General Counsel and Director
|
|
|
October 23, 2025
|
|
Suzanne Niemeyer
|
|
|||||
|
|
|
|
|
|
|
|
|
/s/ James O. Donnally
|
|
|
Director
|
|
|
October 23, 2025
|
|
James O. Donnally
|
|
|||||
|
|
|
|
|
|
|
|
|
/s/ Bruce Brown
|
|
|
Director
|
|
|
October 23, 2025
|
|
Bruce Brown
|
|
|||||
|
|
|
|
|
|
|
|
|
/s/ Elizabeth Williams
|
|
|
Director
|
|
|
October 23, 2025
|
|
Elizabeth Williams
|
|
|||||
|
|
|
|
|
|
|
|
|
/s/ Daniel J. Hennessy
|
|
|
Director
|
|
|
October 23, 2025
|
|
Daniel J. Hennessy
|
|
|||||
|
|
|
|
|
|
|
|
|
/s/ Michael Amalfitano
|
|
|
Director
|
|
|
October 23, 2025
|
|
Michael Amalfitano
|
|
|||||
|
|
|
|
|
|
|
|